{"content":"<li class=\"n-box-item date-title\" data-end=\"1523332799\" data-start=\"1523246400\" data-txt=\"Monday, December 23, 2019\">Monday, April  9, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3344548\" data-ts=\"1523316383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAY\" target=\"_blank\">PAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344548-analysts-verifone-unlikely-to-see-topper-of-3_4b-buyout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts: VeriFone unlikely to see topper of $3.4B buyout</a></h4><ul>   <li>VeriFone Systems (NYSE:<a href='https://seekingalpha.com/symbol/PAY' title='VeriFone Systems, Inc.'>PAY</a>) -- now <font color='green'>up 51%</font> after hours after word of a <a href=\"https://seekingalpha.com/news/3344529-verifone-jumps-50-percent-3_4b-go-private-deal-via-francisco-partners\" target=\"_blank\">$3.4B go-private deal</a> -- isn't likely to see a better bid despite a go-shop period, analysts say.</li>    <li>A 54% premium makes other bidders unlikely, and it's a good deal for the company, says Piper Jaffray's Jason Deleeuw.</li>    <li>Meanwhile, Jefferies says there's unlikely to be a list of suitors looking to disrupt what is a compelling offer that makes sense given the premium and the rapid change on the front-end of payments.</li>    <li>Shares have been down 15% YTD; VeriFone has traded as high as the $23.04/share offer price since summer 2016.</li>    <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344548\" data-linked=\"Analysts: VeriFone unlikely to see topper of $3.4B buyout\" data-tweet=\"$PAY - Analysts: VeriFone unlikely to see topper of $3.4B buyout https://seekingalpha.com/news/3344548-analysts-verifone-unlikely-to-see-topper-of-3_4b-buyout?source=tweet\" data-url=\"https://seekingalpha.com/news/3344548-analysts-verifone-unlikely-to-see-topper-of-3_4b-buyout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344536\" data-ts=\"1523309767\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAY\" target=\"_blank\">PAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344536-after-hours-gainers-losers-04-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (04/09/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/PAY' title='VeriFone Systems, Inc.'>PAY</a> <font color='green'>+51.5%</font>. <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color='green'>+5.5%</font>. SHLD&nbsp;<font color='green'>+2.4%</font>. <a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Ltd. ADS'>SFUN</a>&nbsp;<font color='green'>+2.4%</font>. <a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>&nbsp;<font color='green'>+2.1%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/EMKR' title='EMCORE Corporation'>EMKR</a> <font color='red'>-8.1%</font>. <a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a> <font color='red'>-1.8%</font>. <a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a>&nbsp;<font color='red'>-1.8%.&nbsp;</font><a href='https://seekingalpha.com/symbol/MUX' title='McEwen Mining Inc.'>MUX</a>&nbsp;<font color='red'>-1.4%</font>. <a href='https://seekingalpha.com/symbol/SWN' title='Southwestern Energy Co.'>SWN</a>&nbsp;<font color='red'>-1.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344536\" data-linked=\"After Hours Gainers / Losers (04/09/2018)\" data-tweet=\"$PAY $PAY $CNAT - After Hours Gainers / Losers (04/09/2018) https://seekingalpha.com/news/3344536-after-hours-gainers-losers-04-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344536-after-hours-gainers-losers-04-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344534\" data-ts=\"1523309279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PME\" target=\"_blank\">PME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344534-pingtan-marineplus-12_3-vessel-approvals-will-boost-capacity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pingtan Marine +12.3% as vessel approvals will boost capacity</a></h4><ul>   <li>Pingtan Marine Enterprise (NASDAQ:<a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a>) is <font color='green'>up 12.3%</font> after hours, building on regular session gains, after news that 27 of its fishing vessels have <a href=\"https://seekingalpha.com/pr/17124167-pingtan-marine-enterprise-expects-significantly-increase-current-production-capacity\" target=\"_blank\">gotten approval for operations</a> in Indian Ocean international waters.</li>    <li>The approvals, from China's Ministry of Agriculture and Rural Affairs, means a significant increase in production capacity.</li>    <li>The company will modify and rebuild the vessels to meet requirements and&nbsp; increase gross tonnage.</li>    <li>Of the 27, seven will be modified as light luring seine fishing vessels with annual harvest capacity of 6,000-8,000 tons each; the other 20 will be modified as squid jigging vessels with annual capacity of 2,000-3,000 tons each.</li>    <li>For 2017, PME's annual sales volume was 17,986 tons (for $63.2M revenue); the 27 vessels are expected to increase total annual harvest capacity by 80,000-110,000 tons.</li>    <li>Shares had <font color='green'>gained 9.6%</font> during Nasdaq market hours today</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344534\" data-linked=\"Pingtan Marine +12.3% as vessel approvals will boost capacity\" data-tweet=\"$PME - Pingtan Marine +12.3% as vessel approvals will boost capacity https://seekingalpha.com/news/3344534-pingtan-marineplus-12_3-vessel-approvals-will-boost-capacity?source=tweet\" data-url=\"https://seekingalpha.com/news/3344534-pingtan-marineplus-12_3-vessel-approvals-will-boost-capacity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344529\" data-ts=\"1523308964\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAY\" target=\"_blank\">PAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344529-verifone-jumps-50-on-3_4b-go-private-deal-via-francisco-partners\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VeriFone jumps 50% on $3.4B go-private deal via Francisco Partners</a></h4><ul>   <li>VeriFone Systems (NYSE:<a href='https://seekingalpha.com/symbol/PAY' title='VeriFone Systems, Inc.'>PAY</a>) has <font color='green'>jumped 50%</font> after hours on word of a <a href=\"https://seekingalpha.com/pr/17124274-verifone-acquired-francisco-partners-3_4-billion\" target=\"_blank\">$3.4B deal</a> to be acquired by Francisco Partners along with British Columbia Investment Management.</li>    <li>The private-equity firm is offering $23.04/share in cash. VeriFone closed today at $15 and is quoting at $22.59 in postmarket action.</li>    <li>The $3.4B value includes VeriFone's net debt.</li>    <li>VeriFone's board has unanimously approved the deal and urges the same from shareholders.</li>    <li>The deal's not subject to financing and is expected to close in Q3; it includes a go-shop period until May 24.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344529\" data-linked=\"VeriFone jumps 50% on $3.4B go-private deal via Francisco Partners\" data-tweet=\"$PAY - VeriFone jumps 50% on $3.4B go-private deal via Francisco Partners https://seekingalpha.com/news/3344529-verifone-jumps-50-on-3_4b-go-private-deal-via-francisco-partners?source=tweet\" data-url=\"https://seekingalpha.com/news/3344529-verifone-jumps-50-on-3_4b-go-private-deal-via-francisco-partners\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344526\" data-ts=\"1523308298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBEV\" target=\"_blank\">NBEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344526-new-age-beveragesminus-11_5-on-5m-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Age Beverages -11.5% on $5M share offering</a></h4><ul>   <li>New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) has <font color='red'>fallen another 11.5%</font> after Bloomberg reports an upcoming $5M stock offering will come at $1.75/share through Maxim Group.</li>    <li>Thats a 15.9% discount. The stock closed <font color='red'>down 1.9%</font> to $2.08 today; quotes after hours are coming at $1.84.</li>    <li>The company will use proceeds for buying new inventory for newly gained distribution, as well as general working capital.</li>    <li>Shares tumbled double digits on March 26 after the company said it might <a href=\"https://seekingalpha.com/news/3341586-new-age-beverages-drops-disclosing-potential-share-offering\" target=\"_blank\">sell up to $20M worth</a> of shares through B. Riley.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344526\" data-linked=\"New Age Beverages -11.5% on $5M share offering\" data-tweet=\"$NBEV - New Age Beverages -11.5% on $5M share offering https://seekingalpha.com/news/3344526-new-age-beveragesminus-11_5-on-5m-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3344526-new-age-beveragesminus-11_5-on-5m-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344522\" data-ts=\"1523307530\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTVT\" target=\"_blank\">VTVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344522-vtv-therapeutics-azeliragon-flunks-late-stage-alzheimers-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">vTv Therapeutics&#39; azeliragon flunks late-stage Alzheimer&#39;s study</a></h4><ul><li>Thinly traded micro cap vTv Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a>) is set for a robust down move on the heels of its <a href=\"https://seekingalpha.com/pr/17124249-vtv-therapeutics-announces-topline-results-first-steadfast-phase-3-study-evaluating\" target=\"_blank\">announcement </a>that a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02080364?titles=steadfast&amp;spons=vtv+therapeutics&amp;phase=2&amp;rank=1\" target=\"_blank\">STEADFAST</a>, assessing lead candidate azeliragon in patients with mild Alzheimer's disease failed to achieve either co-primary endpoint.</li><li>Specifically, azeliragon failed to sufficiently separate from placebo as measured by two scales called ADAS-cog and CDR-sb.</li><li>The company intends to terminate current clinical trials of azeliragon, including the open-label extension study and Part B of STEADFAST.</li><li>CEO Steve Holcombe says, &ldquo;We will continue to analyze the datasets and trends within subgroups from both Part A and Part B to determine if there are potential benefits or future uses and applications for azeliragon. On behalf of vTv Therapeutics, we&rsquo;d like to extend our most sincere and heartfelt gratitude to study participants, their families, physicians and caregivers for their commitment to this important study.&rdquo;</li><li>Shares will resume trading at 5:15 pm ET.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344522\" data-linked=\"vTv Therapeutics&#39; azeliragon flunks late-stage Alzheimer&#39;s study\" data-tweet=\"$VTVT - vTv Therapeutics&#39; azeliragon flunks late-stage Alzheimer&#39;s study https://seekingalpha.com/news/3344522-vtv-therapeutics-azeliragon-flunks-late-stage-alzheimers-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3344522-vtv-therapeutics-azeliragon-flunks-late-stage-alzheimers-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344521\" data-ts=\"1523307395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WATT\" target=\"_blank\">WATT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344521-energousplus-25-on-fcc-certification-of-near-field-transmitter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energous +25% on FCC certification of near field transmitter</a></h4><ul><li>Energous (NASDAQ:<a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a>) <a href=\"https://seekingalpha.com/pr/17124232-energous-receives-fcc-certification-near-field-wireless-charging-transmitter-running-900-mhz\" target=\"_blank\">announces</a> the FCC certification of its WattUp Near Field Transmitter.</li><li>The transmitter, running at 900MHz, was certified under Part 18 of the FCC requirements.</li><li>Energous shares are&nbsp;<font color='green'>up 25%</font>&nbsp;aftermarket to $20.85.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320092-energous-plus-63-percent-fcc-certification\" target=\"_blank\">Energous +63% on FCC certification</a> (Dec. 26, 2017)</li><li>Correction: Post updated to correct typo.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344521\" data-linked=\"Energous +25% on FCC certification of near field transmitter\" data-tweet=\"$WATT - Energous +25% on FCC certification of near field transmitter https://seekingalpha.com/news/3344521-energousplus-25-on-fcc-certification-of-near-field-transmitter?source=tweet\" data-url=\"https://seekingalpha.com/news/3344521-energousplus-25-on-fcc-certification-of-near-field-transmitter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>66&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344520\" data-ts=\"1523307040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344520-morgan-stanley-upgrades-nvidia-to-20-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley upgrades Nvidia to 20% upside</a></h4><ul><li>        Morgan Stanley <a href=\"https://www.streetinsider.com/Hot+Upgrades/Morgan+Stanley+Upgrades+NVIDIA+%28NVDA%29+to+Overweight/14036758.html\" target=\"_blank\">upgrades</a> Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) from Equal Weight to Overweight.</li><li>               Price target: $258, a 20% upside to today&rsquo;s close.&nbsp;</li><li>                  Nvidia shares are&nbsp;<font color='green'>up 2%&nbsp;</font>aftermarket to $219.97.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3344520\" data-linked=\"Morgan Stanley upgrades Nvidia to 20% upside\" data-tweet=\"$NVDA - Morgan Stanley upgrades Nvidia to 20% upside https://seekingalpha.com/news/3344520-morgan-stanley-upgrades-nvidia-to-20-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3344520-morgan-stanley-upgrades-nvidia-to-20-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344516\" data-ts=\"1523306162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTVT\" target=\"_blank\">VTVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344516-trading-in-vtv-therapeutics-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading in vTv Therapeutics halted pending news</a></h4><ul><li>Nasdaq has suspended trading in vTv Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a>) pending the release of news. The likely reason is a data readout from the STEADFAST study of Alzheimer's candidate azeliragon.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270940-part-b-enrollment-completed-vtv-therapeutics-late-stage-study-alzheimers-candidate-azeliragon\" target=\"_blank\">Part B enrollment completed in vTv Therapeutics' late-stage study of Alzheimer's candidate azeliragon, top-line data expected next year</a> (June 1, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344516\" data-linked=\"Trading in vTv Therapeutics halted pending news\" data-tweet=\"$VTVT - Trading in vTv Therapeutics halted pending news https://seekingalpha.com/news/3344516-trading-in-vtv-therapeutics-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3344516-trading-in-vtv-therapeutics-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344513\" data-ts=\"1523305650\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344513-apple-reaches-100-renewable-energy-goal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple reaches 100% renewable energy goal</a></h4><ul><li>Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) hits its goal of running all its operations off <a href=\"https://www.fastcompany.com/40554151/how-apple-got-to-100-renewable-energy-the-right-way\" target=\"_blank\">100% renewable energy</a>.</li><li>The figure includes all of Apple&rsquo;s own operations including the data centers and retail stores but doesn&rsquo;t include third-party suppliers or manufacturers.</li><li>Apple went from 16% to renewable energy to 100% within eight years. CO2 emissions fell 58%.</li><li>Read more about Apple&rsquo;s path to green energy at <a href=\"https://www.fastcompany.com/40554151/how-apple-got-to-100-renewable-energy-the-right-way\" target=\"_blank\">Fast Company</a>.</li><li>Apple shares are&nbsp;<font color='green'>up 0.1%</font>&nbsp;aftermarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344513\" data-linked=\"Apple reaches 100% renewable energy goal\" data-tweet=\"$AAPL - Apple reaches 100% renewable energy goal https://seekingalpha.com/news/3344513-apple-reaches-100-renewable-energy-goal?source=tweet\" data-url=\"https://seekingalpha.com/news/3344513-apple-reaches-100-renewable-energy-goal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>82&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344512\" data-ts=\"1523305477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EMKR\" target=\"_blank\">EMKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344512-emcore-reports-preliminary-q2-results-sharesminus-10-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EMCORE reports preliminary Q2 results; shares -10% AH</a></h4><ul>     <li>EMCORE (NASDAQ:<a href='https://seekingalpha.com/symbol/EMKR' title='EMCORE Corporation'>EMKR</a>) expects Q2 revenue of ~$18M - $19M vs. a consensus of $21.75M and below its prior guidance of $21M - $23M.</li>     <li>Jeffrey Rittichier, EMCORE's President and CEO commented, &ldquo;CATV experienced significant demand shortfall from one major customer but saw bright spots in terms of LEML adoption and strength from our other customers. During the quarter, our Chip and Navigation businesses performed well and demonstrated the expected strength in demand.&rdquo;</li><li>Shares&nbsp;<font color='red'>-10% AH</font></li><li><a href=\"https://seekingalpha.com/pr/17124196-emcore-corporation-announces-preliminary-financial-results-second-fiscal-quarter-ended-march\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3344512\" data-linked=\"EMCORE reports preliminary Q2 results; shares -10% AH\" data-tweet=\"$EMKR - EMCORE reports preliminary Q2 results; shares -10% AH https://seekingalpha.com/news/3344512-emcore-reports-preliminary-q2-results-sharesminus-10-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/3344512-emcore-reports-preliminary-q2-results-sharesminus-10-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344505\" data-ts=\"1523304733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHHBY\" target=\"_blank\">RHHBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344505-roche-suspends-mid-stage-study-of-tecentriq-and-cotellic-combo-in-late-stage-crc-exelixis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roche suspends mid-stage study of Tecentriq and Cotellic combo in late-stage CRC; Exelixis down 7%</a></h4><ul><li>Roche (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a>) collaboration partner Exelixis (<a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a> <font color='red'>-6.6%</font>) ended the session in the red in response to Roche's <a href=\"https://twitter.com/AndyBiotech/status/983410946222837760\" target=\"_blank\">suspension </a>of the Phase 2 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02291289\" target=\"_blank\">MODUL</a> study assessing, among other combination therapies, TECENTRIQ (atezolizumab) plus Exelixis' COTELLIC (cobimetinib) in patients with metastatic colorectal cancer &#40;CRC&#41;.</li><li>Roche took action after a review of cohort 4 data by the independent Data Monitoring Committee which was apparently unfavorable and bodes ill for the readout from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02788279?intr=Atezolizumab%2C+cobimetinib&amp;spons=roche&amp;rank=5\" target=\"_blank\">Phase 3 study</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344505\" data-linked=\"Roche suspends mid-stage study of Tecentriq and Cotellic combo in late-stage CRC; Exelixis down 7%\" data-tweet=\"$RHHBY $RHHBY $EXEL - Roche suspends mid-stage study of Tecentriq and Cotellic combo in late-stage CRC; Exelixis down 7% https://seekingalpha.com/news/3344505-roche-suspends-mid-stage-study-of-tecentriq-and-cotellic-combo-in-late-stage-crc-exelixis?source=tweet\" data-url=\"https://seekingalpha.com/news/3344505-roche-suspends-mid-stage-study-of-tecentriq-and-cotellic-combo-in-late-stage-crc-exelixis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344499\" data-ts=\"1523303878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INCY\" target=\"_blank\">INCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344499-failed-combo-studies-to-come-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More failed combo studies to come - Bloomberg</a></h4><ul><li>Bloomberg <a href=\"https://www.bloomberg.com/gadfly/articles/2018-04-09/incyte-cancer-drug-flop-is-costly-and-likely-to-be-duplicated\" target=\"_blank\">reports </a>that the Incyte's (<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color='green'>+2%</font>) recent flop with epacadostat in melanoma is unlikely to be a lone occurrence because of drugmakers' rush into cancer combination therapies for fear of being left behind by competitors.</li><li>There are at least 30 active clinical trials involving epacadostat across a range of cancers, but its prospects have dimmed considerably since melanoma presented the best chance of success. Analysts have trimmed their views of peak sales to $600M from $3B as a result.</li><li>According to the Cancer Research Institute, 469 studies were launched last year involving Merck's KEYTRUDA family of drugs, many of them combinations. There are 251 studies assessing just one combo approach.</li><li>Author Max Nisen says it may be time for investors to rein in their expectations for combo therapies.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344107-incytes-epacadostat-flunks-late-stage-melanoma-study\" target=\"_blank\">Incyte's epacadostat flunks late-stage melanoma study</a> (April 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344499\" data-linked=\"More failed combo studies to come - Bloomberg\" data-tweet=\"$INCY - More failed combo studies to come - Bloomberg https://seekingalpha.com/news/3344499-failed-combo-studies-to-come-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3344499-failed-combo-studies-to-come-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344500\" data-ts=\"1523303815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBX\" target=\"_blank\">GBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344500-greenbrierminus-4-after-wells-fargo-downplays-forecast-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Greenbrier -4% after Wells Fargo downplays forecast boost</a></h4><ul>     <li>Greenbrier (<a href='https://seekingalpha.com/symbol/GBX' title='The Greenbrier Companies, Inc.'>GBX</a> <font color='red'>-4%</font>) falls as much as 4.4% after Wells Fargo cut its price target for the shares to a Street-low $50 from $55, saying the company&rsquo;s <a href=\"https://seekingalpha.com/news/3344197-greenbrier-2-percent-post-q2-results\" target=\"_blank\">increased EPS guidance</a> does not truly reflect a core operations \"beat and raise.\"</li>     <li>Wells says it is unclear what overall impact steel tariffs will have but GBX management has noted customers waiting for better  pricing may not get it with steel costs on the rise, implying the company  is willing and able to offset higher raws going forward</li>     <li>Peers GATX (<a href='https://seekingalpha.com/symbol/GATX' title='GATX Corp.'>GATX</a> <font color='red'>-0.8%</font>), FreightCar America (<a href='https://seekingalpha.com/symbol/RAIL' title='FreightCar America, Inc.'>RAIL</a> <font color='red'>-1.9%</font>) and American Railcar (<a href='https://seekingalpha.com/symbol/ARII' title='American Railcar Industries, Inc.'>ARII</a> <font color='red'>-1.4%</font>) also are lower.</li><li>Source:&nbsp;Bloomberg First Word</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344500\" data-linked=\"Greenbrier -4% after Wells Fargo downplays forecast boost\" data-tweet=\"$GBX $GBX $GATX - Greenbrier -4% after Wells Fargo downplays forecast boost https://seekingalpha.com/news/3344500-greenbrierminus-4-after-wells-fargo-downplays-forecast-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3344500-greenbrierminus-4-after-wells-fargo-downplays-forecast-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344492\" data-ts=\"1523301510\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRWD\" target=\"_blank\">IRWD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344492-ironwood-investor-sarissa-capital-to-nominate-board-member\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ironwood investor Sarissa Capital to nominate board member</a></h4><ul><li>The broad market's rally notwithstanding, Ironwood Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IRWD' title='Ironwood Pharmaceuticals, Inc.'>IRWD</a> <font color='green'>+15.3%</font>) is up a 60% surge in volume in apparent reaction to its <a href=\"https://seekingalpha.com/pr/17123299-ironwood-pharmaceuticals-announces-director-nomination-sarissa-capital\" target=\"_blank\">announcement </a>that investor Sarissa Capital Management LP plans to nominate chief investment officer Alex Denner to the Board.</li><li>The company says it is open to considering Mr. Denner and the Board's Governance and Nominating Committee will carefully review his nomination.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344492\" data-linked=\"Ironwood investor Sarissa Capital to nominate board member\" data-tweet=\"$IRWD - Ironwood investor Sarissa Capital to nominate board member https://seekingalpha.com/news/3344492-ironwood-investor-sarissa-capital-to-nominate-board-member?source=tweet\" data-url=\"https://seekingalpha.com/news/3344492-ironwood-investor-sarissa-capital-to-nominate-board-member\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344490\" data-ts=\"1523300971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHIO\" target=\"_blank\">PHIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344490-rxi-pharma-secures-4_9m-capital-raise-shares-down-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RXi Pharma secures $4.9M capital raise; shares down 5%</a></h4><ul><li>Rxi Pharmaceuticals (RXII <font color='red'>-5.4%</font>) inks <a href=\"https://seekingalpha.com/pr/17124033-rxi-pharmaceuticals-announces-4_9-million-registered-direct-offering-priced-market\" target=\"_blank\">agreements </a>with institutional investors for the sale of ~1.51M shares of common stock at $3.24375 per share yielding gross proceeds of ~$4.9M. Purchasers will also receive unregistered five-year warrants to purchase up to an aggregate of ~1.13M shares of common at $3.15.</li><li>Net proceeds should be ~$4.1M.</li><li><strong>Update</strong>: On Wednesday, April 11, the company <a href=\"https://seekingalpha.com/pr/17126987-rxi-pharmaceuticals-announces-closing-4_9-million-registered-direct-offering\" target=\"_blank\">announced </a>that the offering closed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344490\" data-linked=\"RXi Pharma secures $4.9M capital raise; shares down 5%\" data-tweet=\"$PHIO - RXi Pharma secures $4.9M capital raise; shares down 5% https://seekingalpha.com/news/3344490-rxi-pharma-secures-4_9m-capital-raise-shares-down-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3344490-rxi-pharma-secures-4_9m-capital-raise-shares-down-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344488\" data-ts=\"1523300416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEAR\" target=\"_blank\">HEAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344488-technology-top-5-gainers-losers-of-3-00-pm-04-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 PM (04/09/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/INSG' title='Inseego Corp.'>INSG</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/KONE' title='Kingtone Wirelessinfo Solution Holding Ltd'>KONE</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VEON' title='VEON Ltd. ADS'>VEON</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/INTT' title='inTest Corporation'>INTT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/MBT' title='Mobile TeleSystems'>MBT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/YNDX' title='Yandex N.V.'>YNDX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SMIT' title='Schmitt Industries, Inc.'>SMIT</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344488\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 PM (04/09/2018)\" data-tweet=\"$HEAR $HEAR $MEET - Technology - Top 5 Gainers / Losers as of 3:00 PM (04/09/2018) https://seekingalpha.com/news/3344488-technology-top-5-gainers-losers-of-3-00-pm-04-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344488-technology-top-5-gainers-losers-of-3-00-pm-04-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344487\" data-ts=\"1523300182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAPP\" target=\"_blank\">CAPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344487-corporacion-america-airports-swings-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corporacion America Airports swings lower</a></h4><ul>     <li>Corporacion America Airports (<a href='https://seekingalpha.com/symbol/CAPP' title='Capstone Financial Group Inc.'>OTCPK:CAPP</a>) slides after Citi drops its price target on the Argentinian airport operator to $19.40 from $22.</li>     <li>Citi keeps a Buy rating on Corporacion in place as it points to \"significantly weaker\" Argentine peso/USD forecasts and the valuation on the stock as compared to Mexican airport operators.</li><li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344487\" data-linked=\"Corporacion America Airports swings lower\" data-tweet=\"$CAPP - Corporacion America Airports swings lower https://seekingalpha.com/news/3344487-corporacion-america-airports-swings-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3344487-corporacion-america-airports-swings-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344486\" data-ts=\"1523300130\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CX\" target=\"_blank\">CX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344486-cemex-upgraded-bofa-merrill-lynch-mexican-shares-set-to-rebound\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cemex upgraded at BofA Merrill Lynch as Mexican shares set to rebound</a></h4><ul>     <li>Cemex (<a href='https://seekingalpha.com/symbol/CX' title='Cemex, S.A.B. de C.V.'>CX</a> <font color='green'>+3.3%</font>) is higher after BofA&nbsp;Merrill Lynch <a href=\"https://247wallst.com/infrastructure/2018/04/09/cemex-upgrade-sees-bad-news-all-priced-in/\" target=\"_blank\">upgrades shares to Buy</a> from Neutral with an $8.50 price target, raised from $8, believing a NAFTA deal is within reach and that Mexican stocks will rebound with CX leading the group to the upside.</li>     <li>BAML says CX's 10% free cash flow yield has become too attractive to ignore, even with upcoming Mexican elections whose risk is more than priced in and already reflected in the firm&rsquo;s estimates.</li>     <li>The firm also thinks most of CX's cement markets are generating strong earnings, and that the stock now is the least expensive among Mexican large-caps.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344486\" data-linked=\"Cemex upgraded at BofA Merrill Lynch as Mexican shares set to rebound\" data-tweet=\"$CX - Cemex upgraded at BofA Merrill Lynch as Mexican shares set to rebound https://seekingalpha.com/news/3344486-cemex-upgraded-bofa-merrill-lynch-mexican-shares-set-to-rebound?source=tweet\" data-url=\"https://seekingalpha.com/news/3344486-cemex-upgraded-bofa-merrill-lynch-mexican-shares-set-to-rebound\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344484\" data-ts=\"1523298711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344484-morgan-stanley-internet-stocks-in-penalty-box-on-regulation-risks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley: Internet stocks in &quot;penalty box&quot; on regulation risks</a></h4><ul><li>           Morgan Stanley <a href=\"https://www.marketwatch.com/story/internet-stocks-could-remain-in-the-penalty-box-for-months-says-morgan-stanley-2018-04-09?siteid=rss&amp;rss=1\" target=\"_blank\">says</a> internet stocks could &ldquo;remain in the penalty box for some time&rdquo; due to rising regulatory risks. </li><li> Full quote from the note to clients: &ldquo;We saw early signs of some weakness in internet stocks around [Q4] earnings and more recently have seen rising worry of regulatory risks. The fundamentals may well be fine long term but we think the group may remain in the penalty box for some time.&rdquo; </li><li> Morgan Stanley doesn&rsquo;t expect regulations to come before the November midterm elections. &nbsp; </li><li> Stocks that could move on the note: Facebook (<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a> <font color='green'>+1.8%</font>), Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='green'>+1.6%</font>), Netflix (<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a> <font color='green'>+2.4%</font>), and Alphabet (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='green'>+2.5%</font>). </li><li> Morgan Stanley is also cautious on semiconductors, saying it has &ldquo;doubts about the sustainability of the semis cycle.&rdquo; </li><li> Semiconductors continue to push up after Evercore&rsquo;s positive note this morning. The Philadelphia Semiconductor Index is&nbsp;<font color='green'>up 2.4%.</font>&nbsp; </li><li>Semiconductor ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3344484\" data-linked=\"Morgan Stanley: Internet stocks in &quot;penalty box&quot; on regulation risks\" data-tweet=\"$FB $FB $AMZN - Morgan Stanley: Internet stocks in &quot;penalty box&quot; on regulation risks https://seekingalpha.com/news/3344484-morgan-stanley-internet-stocks-in-penalty-box-on-regulation-risks?source=tweet\" data-url=\"https://seekingalpha.com/news/3344484-morgan-stanley-internet-stocks-in-penalty-box-on-regulation-risks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344481\" data-ts=\"1523297567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MON\" target=\"_blank\">MON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344481-wsj-doj-to-allow-bayer-s-acquisition-of-monsanto\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: DoJ to allow Bayer\u2019s acquisition of Monsanto</a></h4><ul>     <li>Monsanto (<a href='https://seekingalpha.com/symbol/MON' title='Monsanto Company'>MON</a> <font color='green'>+6.8%</font>) spikes in reaction to a <em>WSJ</em> report that the U.S. Justice Department has decided to <a href=\"https://www.wsj.com/articles/justice-department-to-allow-bayers-acquisition-of-monsanto-after-companies-make-concessions-sources-say-1523296246\" target=\"_blank\">approve its pending acquisition</a> by Bayer (<a href='https://seekingalpha.com/symbol/BAYRY' title='Bayer A.G. ADR'>OTCPK:BAYRY</a> <font color='green'>+3.1%</font>), after the companies pledged to sell off additional assets to secure government antitrust approval.</li>     <li>An agreement in principle between the companies and the DoJ, brokered in recent days, mark a breakthrough in the U.S. merger review process, according to the report, which says Bayer CEO Werner Baumann and MON CEO Hugh Grant recently met with DoJ officials in Washington to help secure a deal.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3344481\" data-linked=\"WSJ: DoJ to allow Bayer\u2019s acquisition of Monsanto\" data-tweet=\"$MON $MON $BAYRY - WSJ: DoJ to allow Bayer\u2019s acquisition of Monsanto https://seekingalpha.com/news/3344481-wsj-doj-to-allow-bayer-s-acquisition-of-monsanto?source=tweet\" data-url=\"https://seekingalpha.com/news/3344481-wsj-doj-to-allow-bayer-s-acquisition-of-monsanto\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344480\" data-ts=\"1523297448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AJG\" target=\"_blank\">AJG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344480-arthur-j-gallagher-co-acquires-integrity-transportation-insurance-agency\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arthur J. Gallagher &amp; Co. acquires Integrity Transportation Insurance Agency</a></h4><ul>     <li>Arthur J. Gallagher &amp; Co. (<a href='https://seekingalpha.com/symbol/AJG' title='Arthur J.Gallagher & Co.'>AJG</a> <font color='green'>+1.6%</font>) announced the acquisition of Houston-based Integrity Transportation Insurance Agency, LLC.  Terms of the transaction were not disclosed.</li>     <li>Integrity Transportation Insurance Agency is a retail property/casualty broker serving Texas-based transportation clients, primarily long-haul truckers.</li><li><a href=\"https://seekingalpha.com/pr/17123597-arthur-j-gallagher-and-co-acquires-integrity-transportation-insurance-agency-llc\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3344480\" data-linked=\"Arthur J. Gallagher &amp; Co. acquires Integrity Transportation Insurance Agency\" data-tweet=\"$AJG - Arthur J. Gallagher &amp; Co. acquires Integrity Transportation Insurance Agency https://seekingalpha.com/news/3344480-arthur-j-gallagher-co-acquires-integrity-transportation-insurance-agency?source=tweet\" data-url=\"https://seekingalpha.com/news/3344480-arthur-j-gallagher-co-acquires-integrity-transportation-insurance-agency\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344478\" data-ts=\"1523296810\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CENX\" target=\"_blank\">CENX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344478-energy-materials-top-gainers-losers-of-2-00-pm-04-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm (04/09/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/TMQ' title='Trilogy Metals Inc.'>TMQ</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='green'>+8%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/MTL' title='Mechel OAO'>MTL</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/MBII' title='Marrone Bio Innovations, Inc.'>MBII</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CRK' title='Comstock Resources Inc.'>CRK</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ACET' title='Aceto Corporation'>ACET</a> <font color='red'>-6%</font>.</li>      &nbsp;&nbsp;</ul><div class=\"tiny-share-widget\" data-id=\"3344478\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm (04/09/2018)\" data-tweet=\"$CENX $CENX $TMQ - Energy/Materials - Top Gainers / Losers as of 2:00 pm (04/09/2018) https://seekingalpha.com/news/3344478-energy-materials-top-gainers-losers-of-2-00-pm-04-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344478-energy-materials-top-gainers-losers-of-2-00-pm-04-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344552\" data-ts=\"1523296630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCEL\" target=\"_blank\">FCEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344552-fuelcell-energy-to-sell-fuel-cell-power-plant-project-to-nrg-yield\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FuelCell Energy to sell fuel cell power plant project to NRG Yield</a></h4><ul>     <li>FuelCell Energy (<a href='https://seekingalpha.com/symbol/FCEL' title='FuelCell Energy, Inc.'>FCEL</a> <font color='green'>+3.9%</font>) is higher following news it <a href=\"https://seekingalpha.com/pr/17123477-fuelcell-energy-enters-definitive-agreement-sell-project-nrg-yield\" target=\"_blank\">agreed to sell</a> the project company that owns the 2.8 MW fuel cell power plant project located at the Tulare Waste Water Treatment Facility in California to NRG Yield (NYLD <font color='green'>+1.4%</font>) for an undisclosed sum.</li>     <li>The project company, under NYLD's new ownership, will deliver clean power and heat to the city of Tulare under a multi-year power purchase agreement, while FCEL will operate and maintain the power plant under a 20-year service agreement with the project company.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344552\" data-linked=\"FuelCell Energy to sell fuel cell power plant project to NRG Yield\" data-tweet=\"$FCEL $FCEL $CWEN - FuelCell Energy to sell fuel cell power plant project to NRG Yield https://seekingalpha.com/news/3344552-fuelcell-energy-to-sell-fuel-cell-power-plant-project-to-nrg-yield?source=tweet\" data-url=\"https://seekingalpha.com/news/3344552-fuelcell-energy-to-sell-fuel-cell-power-plant-project-to-nrg-yield\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>184&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344462\" data-ts=\"1523296078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMIT\" target=\"_blank\">SMIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344462-schmitt-industries-down-8-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schmitt Industries down 8% post Q3 results</a></h4><ul>     <li>Schmitt Industries (<a href='https://seekingalpha.com/symbol/SMIT' title='Schmitt Industries, Inc.'>SMIT</a> <font color='red'>-8.5%</font>) reported Q3 revenue of $3.24M (+1.2% Y/Y). Segment sales: Balancer 15.6% Y/Y to $2.14M and Measurement -18.4% Y/Y to $1.1M.</li>     <li>Q3 gross margin&nbsp;<font color='green'>increased by 287 bps</font>&nbsp;to 40.8%.</li>     <li>Overall operating margin&nbsp;<font color='green'>improved by 185 bps</font>&nbsp;to -1.23%.</li>     <li>Q3 Expenses: Operating +3.8% Y/Y to $1.36M; GA&amp;S +1.8% Y/Y to $1.28M.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3344248-schmitt-industries-reports-q3-results\" target=\"_blank\">Schmitt Industries reports Q3 results</a> (April 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344462\" data-linked=\"Schmitt Industries down 8% post Q3 results\" data-tweet=\"$SMIT - Schmitt Industries down 8% post Q3 results https://seekingalpha.com/news/3344462-schmitt-industries-down-8-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3344462-schmitt-industries-down-8-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344468\" data-ts=\"1523293257\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LUK-OLD\" target=\"_blank\">LUK-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344468-financials-top-5-gainers-losers-of-1-00-pm-04-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (04/09/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LUK-OLD' title='Leucadia National Corporation'>LUK-OLD</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/LEJU' title='Leju Holdings Limited'>LEJU</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/LTS' title='Ladenburg Thalmann Financial Services Inc.'>LTS</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/MLP' title='Maui Land & Pineapple Company, Inc.'>MLP</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NMIH' title='NMI Holdings, Inc.'>NMIH</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/ESNT' title='Essent Group Ltd.'>ESNT</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/RDN' title='Radian Group, Inc.'>RDN</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/MTG' title='MGIC Investment Corporation'>MTG</a> <font color='red'>-14%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344468\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (04/09/2018)\" data-tweet=\"$LUK-OLD $LUK-OLD $FRSX - Financials - Top 5 Gainers / Losers as of 1:00 PM (04/09/2018) https://seekingalpha.com/news/3344468-financials-top-5-gainers-losers-of-1-00-pm-04-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344468-financials-top-5-gainers-losers-of-1-00-pm-04-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344463\" data-ts=\"1523292136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVXS\" target=\"_blank\">AVXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344463-midday-gainers-losers-04-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (04/09/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/AVXS' title='AveXis'>AVXS</a> <font color='green'>+82%</font>. <a href='https://seekingalpha.com/symbol/KONE' title='Kingtone Wirelessinfo Solution Holding Ltd'>KONE</a> <font color='green'>+59%</font>. <a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO'>RGNX</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/ALRN' title='Aileron Therapeutics'>ALRN</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a> <font color='green'>+16%</font>.</li>     <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/MNLO' title='Menlo Therapeutics Inc.'>MNLO</a> <font color='red'>-72%</font>. <a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/NMIH' title='NMI Holdings, Inc.'>NMIH</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/MTL' title='Mechel OAO'>MTL</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/ESNT' title='Essent Group Ltd.'>ESNT</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/RDN' title='Radian Group, Inc.'>RDN</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/MTG' title='MGIC Investment Corporation'>MTG</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/VEON' title='VEON Ltd. ADS'>VEON</a> <font color='red'>-12%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3344463\" data-linked=\"Midday Gainers / Losers (04/09/2018)\" data-tweet=\"$AVXS $AVXS $KONE - Midday Gainers / Losers (04/09/2018) https://seekingalpha.com/news/3344463-midday-gainers-losers-04-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344463-midday-gainers-losers-04-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344460\" data-ts=\"1523291649\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344460-nasdaq-up-over-2-stocks-move-to-session-highs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nasdaq up over 2% as stocks move to session highs</a></h4><ul><li>The major averages have reclaimed a sizable chunk of Friday's big losses, with the Nasdaq&nbsp;<font color='green'>up 2.1%</font>, the S&amp;P 500&nbsp;<font color='green'>1.5%</font>, the DJIA&nbsp;<font color='green'>1.4%</font>, and the Russell 2000&nbsp;<font color='green'>1.2%</font>.</li><li>It's a broad advance, with all S&amp;P 500 sectors in the green, even the defensive utilities.</li><li>The 10-year Treasury yield is bouncing alongside stocks, up 2.1 basis points to 2.80%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344460\" data-linked=\"Nasdaq up over 2% as stocks move to session highs\" data-tweet=\"Nasdaq up over 2% as stocks move to session highs https://seekingalpha.com/news/3344460-nasdaq-up-over-2-stocks-move-to-session-highs?source=tweet\" data-url=\"https://seekingalpha.com/news/3344460-nasdaq-up-over-2-stocks-move-to-session-highs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344448\" data-ts=\"1523290840\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTG\" target=\"_blank\">MTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344448-btig-sees-63-upside-on-mgic-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BTIG sees 63% upside on MGIC shares</a></h4><ul><li>Even though MGIC Investment (<a href='https://seekingalpha.com/symbol/MTG' title='MGIC Investment Corporation'>MTG</a> <font color='red'>-15%</font>)&nbsp;is down sharply today after lowering premium rates, <a href=\"http://researchwiseny.btig.com/ResearchLibraryAnalec/DownloadResearch.aspx?E=bcbifk-b\" target=\"_blank\">BTIG's Mark Palmer still sees an optimistic outlook.</a></li><li>Lower premiums can be offset through increased market-share and volumes to counter the dominance of the FHA in the mortgage insurance market, says Palmer, reiterating his Buy rating and $18 price target.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344403-mortgage-insurers-plunge-mgic-price-cut\" target=\"_blank\">Mortgage insurers plunge on MGIC price cut</a> (April 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344448\" data-linked=\"BTIG sees 63% upside on MGIC shares\" data-tweet=\"$MTG - BTIG sees 63% upside on MGIC shares https://seekingalpha.com/news/3344448-btig-sees-63-upside-on-mgic-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3344448-btig-sees-63-upside-on-mgic-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344454\" data-ts=\"1523290342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXK\" target=\"_blank\">EXK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344454-endeavour-silverplus-3-q1-silver-production-climbs-25-y-y\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endeavour Silver +3% as Q1 silver production climbs 25% Y/Y</a></h4><ul>     <li>Endeavour Silver (<a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a> <font color='green'>+3.3%</font>) is higher after reporting <a href=\"https://seekingalpha.com/pr/17123077-endeavour-silver-produces-1350-840-oz-silver-13208-oz-gold-2_3-million-oz-silver-equivalents\" target=\"_blank\">Q1 silver production jumped 25% Y/Y</a> to more than 1.35M oz. from 1.07M oz. in the prior-year quarter and gold production rose 13% to 13.2K oz. from 11,7K oz. a year ago.</li>     <li>EXK attributes the silver production gains to higher mine output and ore grades at El Cubo and Bola&ntilde;itos, partly offset by lower mine output at Guanacevi as the mine continues to recover from operating issues last year.</li>     <li>EXK says development of the El Compas mine remains on schedule for mine and plant commissioning to begin in April and commercial production to be gin by the end of July.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344454\" data-linked=\"Endeavour Silver +3% as Q1 silver production climbs 25% Y/Y\" data-tweet=\"$EXK - Endeavour Silver +3% as Q1 silver production climbs 25% Y/Y https://seekingalpha.com/news/3344454-endeavour-silverplus-3-q1-silver-production-climbs-25-y-y?source=tweet\" data-url=\"https://seekingalpha.com/news/3344454-endeavour-silverplus-3-q1-silver-production-climbs-25-y-y\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344453\" data-ts=\"1523289682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344453-recode-amazon-led-r-and-d-spending-last-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Recode: Amazon led R&amp;D spending last year</a></h4><ul><li>        Recode <a href=\"https://www.recode.net/2018/4/9/17204004/amazon-research-development-rd\" target=\"_blank\">breaks down</a> the top U.S. companies for R&amp;D spending for the last fiscal year and Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='green'>+2%</font>) leads with $22.6B.</li><li>               Tech companies represented the top five with that list rounded out with Alphabet (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='green'>+2.8%</font>) at $16.6B, Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='green'>+4%</font>) at $13.1B, Microsoft (<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a> <font color='green'>+2.9%</font>) at $12.3B, and Apple (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='green'>+2.4%</font>) at $11.6B. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3344453\" data-linked=\"Recode: Amazon led R&amp;D spending last year\" data-tweet=\"$AMZN $AMZN $GOOG - Recode: Amazon led R&amp;D spending last year https://seekingalpha.com/news/3344453-recode-amazon-led-r-and-d-spending-last-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3344453-recode-amazon-led-r-and-d-spending-last-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344451\" data-ts=\"1523289671\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBSF\" target=\"_blank\">KBSF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344451-consumer-top-gainers-losers-of-12-00-pm-04-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (04/09/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/FORD' title='Forward Industries, Inc.'>FORD</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/RFP' title='Resolute Forest Products, Inc.'>RFP</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RCKY' title='Rocky Brands, Inc.'>RCKY</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344451\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (04/09/2018)\" data-tweet=\"$KBSF $KBSF $PME - Consumer - Top Gainers / Losers as of 12:00 PM (04/09/2018) https://seekingalpha.com/news/3344451-consumer-top-gainers-losers-of-12-00-pm-04-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344451-consumer-top-gainers-losers-of-12-00-pm-04-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344446\" data-ts=\"1523289066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXCYY\" target=\"_blank\">MXCYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344446-metso-to-acquire-swedish-aggregate-equipment-provider\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Metso to acquire Swedish aggregate equipment provider</a></h4><ul>     <li>Metso (<a href='https://seekingalpha.com/symbol/MXCYY' title='Metso Corporation ADR'>OTCQX:MXCYY</a>) <a href=\"https://seekingalpha.com/pr/17123093-metso-agrees-acquire-swedish-aggregate-equipment-provider-p-j-jonsson-och-soner\" target=\"_blank\">has agreed to acquire</a> (subject to customary &amp; other closing conditions) the mobile crushing and screening plant provider P.J. Jonsson och Soner, based in Sweden. Value of the transaction were not disclosed.</li>     <li>The acquisition is expected to close in the Q318.</li>     <li>P.J. Jonsson och S&ouml;ner's sales in the FY17 were&nbsp;&euro;33M.</li>     <li>\"This acquisition is a good strategic fit for Metso, supporting our profitable growth strategy,\" says Markku Simula, president of Metso's Aggregates Equipment business area. \"Joining forces with P.J. Jonsson och S&ouml;ner gives us the opportunity to serve our Nordic customers with complementary offerings,\" he continues.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344446\" data-linked=\"Metso to acquire Swedish aggregate equipment provider\" data-tweet=\"$MXCYY $MXTOF - Metso to acquire Swedish aggregate equipment provider https://seekingalpha.com/news/3344446-metso-to-acquire-swedish-aggregate-equipment-provider?source=tweet\" data-url=\"https://seekingalpha.com/news/3344446-metso-to-acquire-swedish-aggregate-equipment-provider\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344442\" data-ts=\"1523288515\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344442-house-panel-releases-zuckerberg-testimony-we-didnt-enough\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">House panel releases Zuckerberg testimony: &#39;We didn&#39;t do enough&#39;</a></h4><ul>   <li>The House Energy and Commerce Committee has released Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>) chief <a href=\"https://www.cnbc.com/2018/04/09/congress-released-mark-zuckerbergs-prepared-testimony-ahead-of-wednesdays-hearing.html\" target=\"_blank\">Mark Zuckerberg's testimony</a>, and CNBC has printed it -- though it hits familiar themes from Zuckerberg's recent commentary on the company's data-leak scandal.</li>    <li>Shares are <font color='green'>up 1.5%</font> and reaching session highs.</li>    <li>\"It's clear now that we didn't do enough\" to prevent Facebook's good tools from being used for harm, Zuckerberg says in the prepared testimony. \"That goes for fake news, foreign interference in elections, and hate speech, as well as developers and data privacy.</li>    <li>\"We didn't take a broad enough view of our responsibility, and that was a big mistake. It was my mistake, and I'm sorry. I started Facebook, I run it, and I'm responsible for what happens here.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344442\" data-linked=\"House panel releases Zuckerberg testimony: &#39;We didn&#39;t do enough&#39;\" data-tweet=\"$FB - House panel releases Zuckerberg testimony: &#39;We didn&#39;t do enough&#39; https://seekingalpha.com/news/3344442-house-panel-releases-zuckerberg-testimony-we-didnt-enough?source=tweet\" data-url=\"https://seekingalpha.com/news/3344442-house-panel-releases-zuckerberg-testimony-we-didnt-enough\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344440\" data-ts=\"1523288184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTNR\" target=\"_blank\">PTNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344440-israeli-telecoms-enter-rally-in-u-s-trading\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Israeli telecoms enter rally in U.S. trading</a></h4><ul>   <li>Israeli telecom firms are on the move up as a group today.</li>    <li>Cellcom Israel is <font color='green'>up 5.1%</font> in NYSE trading, a bounce off a 52-week low it hit last Wednesday. Partner Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/PTNR' title='Partner Communications Company Ltd.'>PTNR</a>) is <font color='green'>up 3.1%</font> on Nasdaq, and also hit its 52-week low last Wednesday.</li>    <li>Bezeq (<a href='https://seekingalpha.com/symbol/BZQIY' title='Bezeq The Israel Telecommunication Corp Ltd. ADR'>OTCPK:BZQIY</a>) is <font color='green'>up 2.1%</font>, and its foreign shares (<a href='https://seekingalpha.com/symbol/BZQIF' title='Bezeq The Israel Telecommunication Corp Ltd.'>OTCPK:BZQIF</a>) are <font color='green'>up 1.7%</font> OTC.</li>    <li>And B Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/BCOM' title='B Communications Ltd.'>BCOM</a>) is <font color='green'>up 12.6%</font> on Nasdaq.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344440\" data-linked=\"Israeli telecoms enter rally in U.S. trading\" data-tweet=\"$PTNR $PTNR $BZQIY - Israeli telecoms enter rally in U.S. trading https://seekingalpha.com/news/3344440-israeli-telecoms-enter-rally-in-u-s-trading?source=tweet\" data-url=\"https://seekingalpha.com/news/3344440-israeli-telecoms-enter-rally-in-u-s-trading\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344437\" data-ts=\"1523287519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDT\" target=\"_blank\">MDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344437-medtronic-on-go-study-of-renal-denervation-device-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medtronic on go with study of renal denervation device; shares up 1%</a></h4><ul><li>Medtronic (<a href='https://seekingalpha.com/symbol/MDT' title='Medtronic plc'>MDT</a> <font color='green'>+1.4%</font>) announces that the FDA has signed off a new&nbsp;<a href=\"http://newsroom.medtronic.com/phoenix.zhtml?c=251324&amp;p=irol-newsArticle&amp;ID=2341576\" target=\"_blank\">clinical trial</a> evaluating its Symplicity Spyral renal denervation system in patients with high blood pressure.</li><li>The device, approved in over 50 countries, but not in the U.S. or Japan, uses a multi-electrode catheter to deliver radiofrequency &#40;RF&#41; energy that ablates the nerves that lead to and from the kidneys which results in a lowering of blood pressure.</li><li>The efficacy of the procedure has been <a href=\"https://www.massdevice.com/medtronic-readies-pivotal-trial-renal-denervation/\" target=\"_blank\">inconsistent</a>, however. Results from an earlier study, announced in January 2014, failed to achieve the primary endpoint.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344437\" data-linked=\"Medtronic on go with study of renal denervation device; shares up 1%\" data-tweet=\"$MDT - Medtronic on go with study of renal denervation device; shares up 1% https://seekingalpha.com/news/3344437-medtronic-on-go-study-of-renal-denervation-device-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3344437-medtronic-on-go-study-of-renal-denervation-device-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344436\" data-ts=\"1523287469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLT\" target=\"_blank\">HLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344436-hilton-worldwide-secondary-seen-positive\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hilton Worldwide secondary seen as a positive</a></h4><ul> <li>Wolfe Research calls the sale of Hilton Wordwide Holdings (<a href='https://seekingalpha.com/symbol/HLT' title='Hilton Worldwide Holdings'>HLT</a> <font color='green'>+0.7%</font>) shares by HNA Group a positive because it \"eliminates an overhang\" and the hotel company is buying back a large amount of the stock.</li> <li>If the underwriters on the secondary offering exercise all of their option, HNA' stake in Hilton will be down to close to 0%.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3344313-hilton-sets-63_05m-share-secondary-offering\" target=\"_blank\">Hilton sets 63.05M-share secondary offering</a> (April 9)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3344436\" data-linked=\"Hilton Worldwide secondary seen as a positive\" data-tweet=\"$HLT - Hilton Worldwide secondary seen as a positive https://seekingalpha.com/news/3344436-hilton-worldwide-secondary-seen-positive?source=tweet\" data-url=\"https://seekingalpha.com/news/3344436-hilton-worldwide-secondary-seen-positive\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344435\" data-ts=\"1523287243\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TI\" target=\"_blank\">TI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344435-elliott-fight-for-telecom-italia-change-increased-stake-advisory-backing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elliott fight for Telecom Italia change: Increased stake, advisory backing</a></h4><ul>   <li>Elliott Management is pressing its board fight at Telecom Italia (<a href=\"http://seekingalpha.com/symbol/TI\" target=\"_blank\">TI</a> <font color='green'>+0.2%</font>) with an increased stake and new support from shareholder advisory firms.</li>    <li>Paul Singer's firm, which wants to cut the influence of French media giant Vivendi (<a href=\"http://seekingalpha.com/symbol/VIVHY\" target=\"_blank\">VIVHY</a> <font color='green'>+1.2%</font>) and its Vincent Bollore (<a href=\"http://seekingalpha.com/symbol/BOIVF\" target=\"_blank\">BOIVF</a> <font color='green'>+2.8%</font>), has <a href=\"https://seekingalpha.com/filing/3971038\" target=\"_blank\">increased its stake in TI to 8.8%</a>, according to a filing. The bulk of the most recent purchases was made on Friday. The filing also notes options that could bring Elliott's stake closer to 13.7%.</li>    <li>Elliott says it doesn't want to control Telecom Italia but rather submit Italian names in place of Vivendi's boardmembers. TI Chairman Arnaud de Puyfontaine and six other directors <a href=\"https://seekingalpha.com/news/3341095-chairman-six-directors-leave-telecom-italia-amid-fight-elliott\" target=\"_blank\">resigned two weeks ago</a> in a maneuver to force a showdown over control of the board in a May 4 vote.</li>    <li>Meanwhile, Glass Lewis has recommended that TI shareholders <a href=\"https://in.reuters.com/article/telecomitalia-vivendi-board/update-1-telecom-italia-board-faces-challenge-from-activist-elliott-idINL8N1RM1BC\" target=\"_blank\">back Elliott's proposal</a>, as has Institutional Shareholder Services. &ldquo;At this point, Vivendi appears to be more of a liability than an asset for TIM,&rdquo; ISS says in its report.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344435\" data-linked=\"Elliott fight for Telecom Italia change: Increased stake, advisory backing\" data-tweet=\"$TI $TI $VIVHY - Elliott fight for Telecom Italia change: Increased stake, advisory backing https://seekingalpha.com/news/3344435-elliott-fight-for-telecom-italia-change-increased-stake-advisory-backing?source=tweet\" data-url=\"https://seekingalpha.com/news/3344435-elliott-fight-for-telecom-italia-change-increased-stake-advisory-backing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344433\" data-ts=\"1523286939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EFII\" target=\"_blank\">EFII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344433-alliance-packaging-enters-digital-age-direct-to-corrugated-efi-nozomi-ultra-high-speed-inkjet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliance Packaging enters the digital age with direct-to-corrugated EFI Nozomi ultra high speed inkjet printing</a></h4><ul>     <li>Electronics for Imaging (<a href='https://seekingalpha.com/symbol/EFII' title='Electronics for Imaging, Inc.'>EFII</a> <font color='green'>+1.7%</font>) <a href=\"https://seekingalpha.com/pr/17123682-alliance-packaging-enters-digital-age-direct-corrugated-efi-nozomi-ultra-high-speed-inkjet\" target=\"_blank\">has received</a> order for EFI&trade; Nozomi C18000 single-pass corrugated packaging press from Alliance Packaging. </li><li>Alliance Packaging is Northwestern U.S.&rsquo;s largest independent corrugated box manufacturer.</li><li>Alliance Packaging&rsquo;s EFI Nozomi press is the ninth EFI Nozomi transaction completed and shipped as of the end of March 2018.  </li>     <li>&ldquo;We are excited to partner with Alliance Packaging to deliver a high-end, digital production solution that can outperform any other single-pass, direct-to-board technology available today,&rdquo; said Jos&eacute; Luis Ram&oacute;n Moreno, vice president and general manager, EFI Industrial Printing. &ldquo;Alliance Packaging serves many of the leading brands and businesses that call the Pacific Northwest home, and this EFI Nozomi installation has the potential to transform and significantly improve those companies&rsquo; packaging strategies.&rdquo;</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344433\" data-linked=\"Alliance Packaging enters the digital age with direct-to-corrugated EFI Nozomi ultra high speed inkjet printing\" data-tweet=\"$EFII - Alliance Packaging enters the digital age with direct-to-corrugated EFI Nozomi ultra high speed inkjet printing https://seekingalpha.com/news/3344433-alliance-packaging-enters-digital-age-direct-to-corrugated-efi-nozomi-ultra-high-speed-inkjet?source=tweet\" data-url=\"https://seekingalpha.com/news/3344433-alliance-packaging-enters-digital-age-direct-to-corrugated-efi-nozomi-ultra-high-speed-inkjet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344432\" data-ts=\"1523286664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVU\" target=\"_blank\">SVU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344432-supervalu-falls-sale-buzz-wears-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Supervalu falls as sale buzz wears off</a></h4><ul> <li>Supervalu (NYSE:<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a>) is <font color='red'>down 5.4%</font> after last Friday's report of a potential sale fizzles out.</li> <li>A separate Dow Jones story indicates that the company is not in any serious talks about a sale.</li> <li>Shares of Supervalu are swapping hands at $15.85 vs. 52-week trading range of $13.60 to $31.29.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344220-supervalu-shoots-sale-report\" target=\"_blank\">Supervalu shoots up on sale report</a> (April 6)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3344432\" data-linked=\"Supervalu falls as sale buzz wears off\" data-tweet=\"$SVU - Supervalu falls as sale buzz wears off https://seekingalpha.com/news/3344432-supervalu-falls-sale-buzz-wears-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3344432-supervalu-falls-sale-buzz-wears-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344428\" data-ts=\"1523286407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVX\" target=\"_blank\">AVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344428-avxplus-1_9-on-new-product-announcement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AVX +1.9% on new product announcement</a></h4><ul><li>           AVX (NYSE:<a href='https://seekingalpha.com/symbol/AVX' title='AVX Corp.'>AVX</a>) <a href=\"https://seekingalpha.com/pr/17123691-avx-releases-first-industrial-poke-home-connector-without-wire-stop\" target=\"_blank\">releases</a> what it calls the &ldquo;first industrial poke-home connector available without a wire stop.&rdquo; </li><li> The 2.5mm poke-home contact includes a range of compatible wire gauges from 20AWG to 26AWG solid and stranded wire available both with and without a wire step. </li><li> The product is meant for use in solid-state lighting, industrial machine controls, sensors, smart grids, and security systems, to name a few. </li><li> AVX shares are&nbsp;<font color='green'>up 1.9%</font>&nbsp;to $16.38.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3344428\" data-linked=\"AVX +1.9% on new product announcement\" data-tweet=\"$AVX - AVX +1.9% on new product announcement https://seekingalpha.com/news/3344428-avxplus-1_9-on-new-product-announcement?source=tweet\" data-url=\"https://seekingalpha.com/news/3344428-avxplus-1_9-on-new-product-announcement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344426\" data-ts=\"1523286050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVXS\" target=\"_blank\">AVXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344426-healthcare-top-5-gainers-losers-of-11-00-04-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/09/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AVXS' title='AveXis'>AVXS</a> <font color='green'>+78%</font>. <a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO'>RGNX</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/JNCE' title='Jounce Therapeutics'>JNCE</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MNLO' title='Menlo Therapeutics Inc.'>MNLO</a> <font color='red'>-71%</font>. <a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/KOOL' title='Cesca Therapeutics Inc'>KOOL</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='red'>-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344426\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/09/2018)\" data-tweet=\"$AVXS $AVXS $RGNX - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/09/2018) https://seekingalpha.com/news/3344426-healthcare-top-5-gainers-losers-of-11-00-04-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344426-healthcare-top-5-gainers-losers-of-11-00-04-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344424\" data-ts=\"1523285805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VEON\" target=\"_blank\">VEON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344424-russia-media-telecom-firms-follow-market-down-amid-sanction-worries\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Russia media/telecom firms follow market down amid sanction worries</a></h4><ul>   <li>Russian-linked telecom firms are lower today in U.S. trading, following the Russian market lower on worries about new U.S. sanctions.</li>    <li>Veon (NASDAQ:<a href='https://seekingalpha.com/symbol/VEON' title='VEON Ltd. ADS'>VEON</a>), the former VimpelCom, gets a third of its revenue from Russia and is <font color='red'>off 9%</font> today. Russian rival mobile TeleSystems (NYSE:<a href='https://seekingalpha.com/symbol/MBT' title='Mobile TeleSystems'>MBT</a>) is <font color='red'>10.9% lower</font>.</li>    <li>Meanwhile, Russian search engine/aspiring ride-share power Yandex (NASDAQ:<a href='https://seekingalpha.com/symbol/YNDX' title='Yandex N.V.'>YNDX</a>) is <font color='red'>9.7% lower</font> on Nasdaq.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344424\" data-linked=\"Russia media/telecom firms follow market down amid sanction worries\" data-tweet=\"$VEON $VEON $MBT - Russia media/telecom firms follow market down amid sanction worries https://seekingalpha.com/news/3344424-russia-media-telecom-firms-follow-market-down-amid-sanction-worries?source=tweet\" data-url=\"https://seekingalpha.com/news/3344424-russia-media-telecom-firms-follow-market-down-amid-sanction-worries\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344423\" data-ts=\"1523285593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JACK\" target=\"_blank\">JACK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344423-u-s-restaurant-sales-seen-improving\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. restaurant sales seen improving</a></h4><ul> <li>Early indications are that U.S. restaurant sales showed some <a href=\"https://www.cnbc.com/2018/04/09/restaurant-sales-gain-ground-in-march-as-consumers-tax-refunds-roll-in.html\" target=\"_blank\">improvement</a> in March, according to Baird's David Tarantino. The analyst thinks the timing of tax refunds could play into comparisons to a year ago, despite the harsher-than-normal weather in large pockets of the nation.</li> <li>\"We believe chains that cater to lower-income consumers will see greater marginal demand improvement from individual income tax cuts than concepts catering to higher-income customers,\" writes Tarantino</li> <li>He singles out Jack in the Box (<a href='https://seekingalpha.com/symbol/JACK' title='Jack In The Box Inc.'>JACK</a> <font color='green'>+0.6%</font>), Texas Roadhouse (<a href='https://seekingalpha.com/symbol/TXRH' title='Texas Roadhouse, Inc.'>TXRH</a> <font color='red'>-1.5%</font>), McDonald's (<a href='https://seekingalpha.com/symbol/MCD' title='McDonald&#39;s Corporation'>MCD</a> <font color='green'>+0.9%</font>) and Dunkin' Donuts (<a href='https://seekingalpha.com/symbol/DNKN' title='Dunkin&#39; Brands'>DNKN</a> <font color='green'>+0.8%</font>) as chains that could have seen the tax refund boost.</li><li>Baird is positive on the U.S. restaurant sector for the balance of the year.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3344423\" data-linked=\"U.S. restaurant sales seen improving\" data-tweet=\"$JACK $JACK $TXRH - U.S. restaurant sales seen improving https://seekingalpha.com/news/3344423-u-s-restaurant-sales-seen-improving?source=tweet\" data-url=\"https://seekingalpha.com/news/3344423-u-s-restaurant-sales-seen-improving\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344422\" data-ts=\"1523285413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DELL\" target=\"_blank\">DELL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344422-dells-pivotal-software-prices-ipo-592m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dell&#39;s Pivotal Software prices IPO at $592M</a></h4><ul><li>        Dell Technologies (DVMT) division Pivotal Software (NYSE:<a href='https://seekingalpha.com/symbol/PVTL' title='Pivotal Software'>PVTL</a>) expects its IPO to <a href=\"https://www.sec.gov/Archives/edgar/data/1574135/000104746918002636/a2235132zs-1a.htm\" target=\"_blank\">raise up to $592M</a>.</li><li>                  Pivotal will offer 37M Class A shares priced between $14 and $16 per share.    </li><li>               Pivotal had $280.9M in revenue in FY16, $416.3M in FY17, and $509.4M in FY18. Net loss for those same periods was $282.7M, $232.9M, and $163.5M.&nbsp;</li><li>               Subscription revenue was $95M in FY16, $150M in FY17, and $259M in FY18. Last year was the first time subscription revenue exceeded services revenue.&nbsp;</li><li>               Dell needs the IPO to help boost profitability due to a debt burden from the 2016 acquisition of EMC Corp. Dell is also considering a reverse merger with VMware (NYSE:<a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a>) for the same reason.&nbsp;</li><li>               Dell shares are&nbsp;<font color='green'>up 1.9%</font>&nbsp;to $72.66.&nbsp;</li><li>               VMware shares are&nbsp;<font color='green'>up 2.6%</font>&nbsp;to $121.82.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3341360-dell-vmware-pivotal-cloud-venture-files-ipo\" target=\"_blank\">Dell, VMware up as Pivotal cloud venture files for IPO</a> (March 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344422\" data-linked=\"Dell&#39;s Pivotal Software prices IPO at $592M\" data-tweet=\"$DELL $DELL $PVTL - Dell&#39;s Pivotal Software prices IPO at $592M https://seekingalpha.com/news/3344422-dells-pivotal-software-prices-ipo-592m?source=tweet\" data-url=\"https://seekingalpha.com/news/3344422-dells-pivotal-software-prices-ipo-592m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344419\" data-ts=\"1523284711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENT\" target=\"_blank\">ENT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344419-global-eagle-launches-low-cost-in-flight-entertainment-product\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Eagle launches low-cost in-flight entertainment product</a></h4><ul>    <li>Global Eagle Entertainment (<a href=\"http://seekingalpha.com/symbol/ENT\" target=\"_blank\">ENT</a> <font color='green'>+2.2%</font>) has introduced a new <a href=\"https://seekingalpha.com/pr/17123328-global-eagle-launches-airline-industry-s-best-low-cost-wireless-ife-option-airplanes-big\" target=\"_blank\">low-cost in-flight entertainment system</a> for airlines that calls for no hardware installation.</li>    <li>The company's Airconnect Go is a portable video-on-demand solution in a product compact enough to fit in an overhead bin.</li>    <li>Airlines installing it don't need a Supplemental Type Certificate and the inexpensive product is offered on simple commercial terms, Global Eagle says. It hopes the offering appeals to airlines with smaller or diverse fleets more more typical IFE mght not be an option.</li>    <li>The product has 15 hours of battery life streaming concurrently to more than 50 users, and has hot-swappable batteries to ease the duty cycle.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344419\" data-linked=\"Global Eagle launches low-cost in-flight entertainment product\" data-tweet=\"$ENT - Global Eagle launches low-cost in-flight entertainment product https://seekingalpha.com/news/3344419-global-eagle-launches-low-cost-in-flight-entertainment-product?source=tweet\" data-url=\"https://seekingalpha.com/news/3344419-global-eagle-launches-low-cost-in-flight-entertainment-product\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344418\" data-ts=\"1523284691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPG\" target=\"_blank\">CPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344418-crescent-point-board-seats-targeted-p-e-firm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crescent Point board seats targeted by P-E firm</a></h4><ul><li>Crescent Point Energy (<a href='https://seekingalpha.com/symbol/CPG' title='Crescent Point Energy Corp'>CPG</a> <font color='green'>+2.8%</font>) is higher after P-E firm Cation Capital says it plans to  <a href=\"http://business.financialpost.com/news/fp-street/cation-capital-targets-board-seats-at-crescent-point-in-move-energy-company-calls-reckless\" target=\"_blank\">nominate four candidates</a> to the company&rsquo;s board at next month's shareholders meeting.</li><li>Cation Capital, led by the former deputy head of global oil and gas at Macquarie Group, says it is &ldquo;compelled to take this action given the significant  destruction of shareholder value and the abject failure of the Canadian  oil producer&rsquo;s current leadership across all aspects.&rdquo;</li><li>CPG replies that Cation&rsquo;s last-minute demand is  unreasonable and reckless, and that the P-E firm &ldquo;appears to have been  created for the sole purpose of creating conflict and havoc.&rdquo;</li><li>Shares of CPG, which has been selling non-core assets to fund its capital spending program and pay down debt, have dropped 47% over the past 12 months.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344418\" data-linked=\"Crescent Point board seats targeted by P-E firm\" data-tweet=\"$CPG - Crescent Point board seats targeted by P-E firm https://seekingalpha.com/news/3344418-crescent-point-board-seats-targeted-p-e-firm?source=tweet\" data-url=\"https://seekingalpha.com/news/3344418-crescent-point-board-seats-targeted-p-e-firm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344417\" data-ts=\"1523284339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344417-evercore-raises-semi-price-targets-calls-now-buying-opportunity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evercore raises semi price targets, calls now a buying opportunity</a></h4><ul><li>           Evercore ISI says now is a buying opportunity for semiconductors. </li><li>           Firm cites the Philadelphia Semiconductor Index &ldquo;now 10% of its highs, our sense is today is a buying opportunity for those with a 3 plus month time horizon.&rdquo;  </li><li>           Analyst C.J. Muse says China concerns are growing, but semis likely won&rsquo;t feel a direct impact in the near future. And that&rsquo;s offset by a favorable global macro backdrop and rising GDP.  </li><li> Firm&rsquo;s best semi ideas: </li><li> Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='green'>+2.8%</font>) with the data center group expected to grow 15% this year. Firm sees EPS of over $3.65 (consensus: $3.57). Price target raised from $55 to $60 (23% upside to Friday). </li><li> Nvidia (<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color='green'>+3.1%</font>) earnings will stand as a &ldquo;clear catalyst&rdquo; with an earnings upside expected from the tight gaming supply, ongoing DCG ramp, and launch of the Turing graphics cards. Cryptocurrency stands as a headwind. </li><li>           The firm raises its Lam Research (<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a> <font color='green'>+2.8%</font>) CY18 EPS estimate from $17 to $18 and has CY19 EPS at $19.50. Lam could provide earnings upside from rising 3D, NAND, and DRAM complexity. Target increased from $260 to $300 (57% upside to Friday).  </li><li> Firm says ASML (<a href='https://seekingalpha.com/symbol/ASML' title='ASML Holding N.V.'>ASML</a> <font color='green'>+2.5%</font>) will benefit from DRAM and thinks EUV fears are overdone. </li><li> Evercore lowers Teradyne (<a href='https://seekingalpha.com/symbol/TER' title='Teradyne Inc.'>TER</a> <font color='green'>+1.3%</font>) CY18 EPS from $2.70 to $2.50 and says to add a position when the stock dips below $40. </li><li> Source: Bloomberg First Word.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3344417\" data-linked=\"Evercore raises semi price targets, calls now a buying opportunity\" data-tweet=\"$INTC $INTC $NVDA - Evercore raises semi price targets, calls now a buying opportunity https://seekingalpha.com/news/3344417-evercore-raises-semi-price-targets-calls-now-buying-opportunity?source=tweet\" data-url=\"https://seekingalpha.com/news/3344417-evercore-raises-semi-price-targets-calls-now-buying-opportunity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344416\" data-ts=\"1523284218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGIO\" target=\"_blank\">AGIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344416-agios-and-jounce-spike-on-potential-celgene-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agios and Jounce spike on potential Celgene interest</a></h4><ul><li>Agios Pharmaceuticals (<a href='https://seekingalpha.com/symbol/AGIO' title='Agios Pharmaceuticals, Inc.'>AGIO</a> <font color='green'>+8.5%</font>) and Jounce Therapeutics (<a href='https://seekingalpha.com/symbol/JNCE' title='Jounce Therapeutics'>JNCE</a> <font color='green'>+11.1%</font>) perk up on the heels of a Financial Times <a href=\"https://www.ft.com/content/192c3774-390f-11e8-8b98-2f31af407cc8\" target=\"_blank\">article </a>that they would be attractive takeover targets for deal-hungry Celgene (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='green'>+1.1%</font>).</li><li>Agios, already collaborating with Celgene, submitted its U.S. marketing application for leukemia med ivosidenib in December 2017.</li><li>Jounce, also collaborating with Celgene, has a range of cancer programs. Lead candidate is JTX-2011 for solid tumors.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320024-agios-submits-nda-ivosidenib-treatment-relapsed-refractory-aml-idh1-mutation\" target=\"_blank\">Agios submits NDA for Ivosidenib for the treatment of relapsed/refractory AML and an IDH1 mutation</a> (Dec. 26, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344416\" data-linked=\"Agios and Jounce spike on potential Celgene interest\" data-tweet=\"$AGIO $AGIO $JNCE - Agios and Jounce spike on potential Celgene interest https://seekingalpha.com/news/3344416-agios-and-jounce-spike-on-potential-celgene-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3344416-agios-and-jounce-spike-on-potential-celgene-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344413\" data-ts=\"1523283933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRCH\" target=\"_blank\">TRCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344413-torchlight-energy-plans-to-sell-midland-basin-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Torchlight Energy plans to sell Midland Basin assets</a></h4><ul>     <li>Torchlight Energy Resources (<a href='https://seekingalpha.com/symbol/TRCH' title='Torchlight Energy Resources, Inc.'>TRCH</a> <font color='green'>+3.1%</font>) says its board has engaged Roth Capital to <a href=\"https://seekingalpha.com/pr/17123184-torchlight-energy-announces-plan-market-midland-basin-assets\" target=\"_blank\">market its Midland Basin assets</a>, also known as the Hazel Project.</li>     <li>TRCH says it will increase its spending plans for the Orogrande Basin project in the Permian Basin, citing \"recent geologic and operational developments [which] have given us sufficient information to rethink our focus and capital budget.\"</li>     <li>TRCH says it believes \"the best way to move forward is to free up value from the Hazel and devote it to the Orogrande.&rdquo;</li></ul><div class=\"tiny-share-widget\" data-id=\"3344413\" data-linked=\"Torchlight Energy plans to sell Midland Basin assets\" data-tweet=\"$TRCH - Torchlight Energy plans to sell Midland Basin assets https://seekingalpha.com/news/3344413-torchlight-energy-plans-to-sell-midland-basin-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/3344413-torchlight-energy-plans-to-sell-midland-basin-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344408\" data-ts=\"1523283411\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NERV\" target=\"_blank\">NERV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344408-minerva-commences-mid-stage-study-of-minminus-117-in-mdd-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Minerva commences mid-stage study of MIN-117 in MDD; shares up 2%</a></h4><ul><li>Thinly traded micro cap Minerva Neurosciences (<a href='https://seekingalpha.com/symbol/NERV' title='Minerva Neurosciences'>NERV</a> <font color='green'>+2.2%</font>) is up, albeit on light volume, on the heels of its <a href=\"https://seekingalpha.com/pr/17123433-minerva-neurosciences-screens-first-patient-phase-2b-trial-minminus-117-treat-major\" target=\"_blank\">announcement </a>that the first patient has been screened in its <a href=\"https://clinicaltrials.gov/ct2/show/NCT03446846?spons=minerva&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2b clinical trial </a>assessing MIN-117 in patients with major depressive disorder &#40;MDD&#41;.</li><li>The primary endpoint of the study is the change in a scale called MADRS total score from baseline to week 6 versus placebo. According to ClinicalTrials.gov, the estimated primary completion date is April 2019.</li><li><a href=\"http://www.minervaneurosciences.com/innovation-pipeline/min-117/\" target=\"_blank\">MIN-117</a> blocks a subtype of serotonin receptor called 5-HT1A. When blocked, anxiety and mood can be regulated.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344408\" data-linked=\"Minerva commences mid-stage study of MIN-117 in MDD; shares up 2%\" data-tweet=\"$NERV - Minerva commences mid-stage study of MIN-117 in MDD; shares up 2% https://seekingalpha.com/news/3344408-minerva-commences-mid-stage-study-of-minminus-117-in-mdd-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3344408-minerva-commences-mid-stage-study-of-minminus-117-in-mdd-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344407\" data-ts=\"1523283118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNJN\" target=\"_blank\">FNJN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344407-finjanplus-2_1-on-patent-agreements-carbon-black\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finjan +2.1% on patent agreements with Carbon Black</a></h4><ul><li>        Finjan (NASDAQ:<a href='https://seekingalpha.com/symbol/FNJN' title='Finjan Holdings, Inc.'>FNJN</a>) <a href=\"https://seekingalpha.com/pr/17123482-finjan-carbon-black-enter-patent-license-agreement\" target=\"_blank\">enters</a> into a patent license and settlement agreement with Carbon Black that resolves all pending litigation.</li><li>               The two also enter a separate patent cross-license agreement that gives both companies &ldquo;freedom to operate&rdquo; in the other&rsquo;s patent portfolio.&nbsp;</li><li>               Finjan shares are&nbsp;<font color='green'>up 2.1%</font>&nbsp;to $2.91.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344175-finjan-slides-18-percent-post-q1-results\" target=\"_blank\">Finjan slides 18% post Q1 results</a> (April 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344407\" data-linked=\"Finjan +2.1% on patent agreements with Carbon Black\" data-tweet=\"$FNJN - Finjan +2.1% on patent agreements with Carbon Black https://seekingalpha.com/news/3344407-finjanplus-2_1-on-patent-agreements-carbon-black?source=tweet\" data-url=\"https://seekingalpha.com/news/3344407-finjanplus-2_1-on-patent-agreements-carbon-black\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344405\" data-ts=\"1523282867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344405-cleveland-cliffs-to-close-asia-pacific-iron-ore-business-june-30\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleveland-Cliffs to close Asia Pacific Iron Ore business by June 30</a></h4><ul>     <li>Cleveland-Cliffs (<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='red'>-2.2%</font>) discloses that it will <a href=\"https://www.sec.gov/Archives/edgar/data/764065/000076406518000083/a20180406-8xkxapioexitdeci.htm\" target=\"_blank\">permanently close</a> its Asia Pacific Iron Ore mining operations by June 30, citing increasingly discounted prices for lower-iron-content ore, the quality of the remaining iron ore reserves at APIO and the lack of a legitimate offer from a qualified buyer.</li>     <li>CLF estimates total costs to be incurred in connection with the closure of $140M-$170M.</li>     <li>CLF already had announced the planned closure of the APIO segment but the new disclosure commits a specific course of action.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344405\" data-linked=\"Cleveland-Cliffs to close Asia Pacific Iron Ore business by June 30\" data-tweet=\"$CLF - Cleveland-Cliffs to close Asia Pacific Iron Ore business by June 30 https://seekingalpha.com/news/3344405-cleveland-cliffs-to-close-asia-pacific-iron-ore-business-june-30?source=tweet\" data-url=\"https://seekingalpha.com/news/3344405-cleveland-cliffs-to-close-asia-pacific-iron-ore-business-june-30\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344403\" data-ts=\"1523282759\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTG\" target=\"_blank\">MTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344403-mortgage-insurers-plunge-on-mgic-price-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mortgage insurers plunge on MGIC price cut</a></h4><ul><li>MGIC Investment (<a href='https://seekingalpha.com/symbol/MTG' title='MGIC Investment Corporation'>MTG</a> <font color='red'>-15.8%</font>) announces <a href=\"https://seekingalpha.com/pr/17123159-mgic-announces-reduced-borrower-paid-premium-rates\" target=\"_blank\">trimmed borrower-paid</a> premium rates in light of the now-lower corporate tax rates. Prices on the most popular premium brands have been cut an average of 11%.</li><li>The new rates are effective June 4. <a href=\"https://mtg.mgic.com/static-files/ab39cda5-f7bf-4032-bd22-68c521187f8a\" target=\"_blank\">Slide presentation is here</a>.</li><li>Radian (<a href='https://seekingalpha.com/symbol/RDN' title='Radian Group, Inc.'>RDN</a> <font color='red'>-13.8%</font>), Essent Group (<a href='https://seekingalpha.com/symbol/ESNT' title='Essent Group Ltd.'>ESNT</a> <font color='red'>-14.4%</font>), NMI Holdings (<a href='https://seekingalpha.com/symbol/NMIH' title='NMI Holdings, Inc.'>NMIH</a> <font color='red'>-18.9%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344403\" data-linked=\"Mortgage insurers plunge on MGIC price cut\" data-tweet=\"$MTG $MTG $RDN - Mortgage insurers plunge on MGIC price cut https://seekingalpha.com/news/3344403-mortgage-insurers-plunge-on-mgic-price-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3344403-mortgage-insurers-plunge-on-mgic-price-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344400\" data-ts=\"1523282470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344400-successful-late-stage-results-for-mercks-keytruda-in-first-line-lung-cancer-pressures-bristol\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Successful late-stage results for Merck&#39;s Keytruda in first-line lung cancer pressures Bristol-Myers Squibb, down 3%</a></h4><ul><li>Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color='red'>-3.2%</font>) slumps, albeit on light volume, in apparent reaction to Merck's <a href=\"https://seekingalpha.com/pr/17123165-keytruda-pembrolizumab-monotherapy-met-primary-endpoint-phase-3-keynoteminus-042-study\" target=\"_blank\">announcement </a>of positive Phase 3 results for KEYTRUDA (pembrolizumab) in first-line non-small cell lung cancer, a large opportunity for drug markers, especially for the first mover.</li><li>BMY aims to grab a share of the pie with the combination of Opdivo (nivolumab) and Yervoy (ipilimumab).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344328-mercks-keytruda-successful-late-stage-study-first-line-lung-cancer-shares-3-percent-premarket\" target=\"_blank\">Merck's Keytruda successful in late-stage study in first-line lung cancer; shares up 3% premarket</a> (April 9)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3327974-bristol-myers-opdivo-yervoy-combo-successful-late-stage-lung-cancer-study-shares-ahead-3\" target=\"_blank\">Bristol-Myers' Opdivo/Yervoy combo successful in late-stage lung cancer study; shares ahead 3% premarket</a> (Feb. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344400\" data-linked=\"Successful late-stage results for Merck&#39;s Keytruda in first-line lung cancer pressures Bristol-Myers Squibb, down 3%\" data-tweet=\"$BMY - Successful late-stage results for Merck&#39;s Keytruda in first-line lung cancer pressures Bristol-Myers Squibb, down 3% https://seekingalpha.com/news/3344400-successful-late-stage-results-for-mercks-keytruda-in-first-line-lung-cancer-pressures-bristol?source=tweet\" data-url=\"https://seekingalpha.com/news/3344400-successful-late-stage-results-for-mercks-keytruda-in-first-line-lung-cancer-pressures-bristol\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344393\" data-ts=\"1523282323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LUK-OLD\" target=\"_blank\">LUK-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344393-leucadia-up-8-after-announcing-strategic-transformation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leucadia up 8% after announcing strategic transformation</a></h4><ul><li>Among a sizable number of moves announced today is the sale of 48% of National Beef at a $2.3B enterprise value. The exit brings Leucadia's (NYSE:<a href='https://seekingalpha.com/symbol/LUK-OLD' title='Leucadia National Corporation'>LUK-OLD</a>) stake down to 31% and allows the company to deconsolidate the business. Leucadia expects to get about $1.05B in cash from the sale, and book a pretax gain of $800M-$850M.</li><li>Also inked is a sale of 100% of Leucadia's interest in auto dealer group Garcadia at a $675M enterprise value, or a net $425M to the company; pre-tax gain is seen at $220M.</li><li>Now more of a pure-play financial services company, LUK sets a vote at the upcoming annual meeting to change its name to Jefferies Financial Group.</li><li>Also, the board doubles the buyback approval to 25M shares.</li><li>FQ1 EPS is seen at $0.32-$0.35.</li><li><a href=\"https://seekingalpha.com/pr/17123176-leucadia-national-corporation-announces-strategic-transactions-complete-transformation\" target=\"_blank\">More here</a></li><li>Shares&nbsp;<font color='green'>up 8%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3344393\" data-linked=\"Leucadia up 8% after announcing strategic transformation\" data-tweet=\"$LUK-OLD - Leucadia up 8% after announcing strategic transformation https://seekingalpha.com/news/3344393-leucadia-up-8-after-announcing-strategic-transformation?source=tweet\" data-url=\"https://seekingalpha.com/news/3344393-leucadia-up-8-after-announcing-strategic-transformation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344398\" data-ts=\"1523282112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIA\" target=\"_blank\">VIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344398-viacoms-request-get-41_5-stake-in-cbs-combo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viacom&#39;s request would get it 41.5% stake in CBS combo</a></h4><ul>   <li>Viacom's (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> <font color='green'>+4.1%</font>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='red'>-0.2%</font>) increased ask of 0.68 shares of CBS (NYSE:<a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a>) for each Viacom B share would give Viacom holders a 41.5% stake in a combined company, CNBC's David Faber says.</li>    <li>But CBS thinks Viacom's estimate of up to $1B in cost synergies is \"way off.\"</li>    <li>With CBS <font color='green'>up 0.5%</font> to $53.09 and <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='red'>down 0.2%</font> to $30.85, the new request from Viacom currently values it at $36.10 per B share.</li>    <li>Still no progress on a major holdup, in whether Viacom CEO Bob Bakish would be president/COO at the new combination, vs. Les Moonves' preference for his own lieutenant, Joe Ianniello. Faber says it's expected Shari Redstone will start replacing board members if Bakish doesn't get the slot.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3344306-viacom-asks-cbs-raise-merger-bid\" target=\"_blank\">Viacom asks CBS to raise merger bid</a> (Apr. 09 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344398\" data-linked=\"Viacom&#39;s request would get it 41.5% stake in CBS combo\" data-tweet=\"$VIA $VIA $VIAB - Viacom&#39;s request would get it 41.5% stake in CBS combo https://seekingalpha.com/news/3344398-viacoms-request-get-41_5-stake-in-cbs-combo?source=tweet\" data-url=\"https://seekingalpha.com/news/3344398-viacoms-request-get-41_5-stake-in-cbs-combo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344390\" data-ts=\"1523280531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344390-nokia-ranked-no-1-in-china-mobiles-central-network-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nokia ranked No. 1 in China Mobile&#39;s central network bid</a></h4><ul>   <li>Nokia (NYSE:<a href='https://seekingalpha.com/symbol/NOK' title='Nokia Corporation'>NOK</a>) says China Mobile (NYSE:<a href='https://seekingalpha.com/symbol/CHL' title='China Mobile Limited'>CHL</a>) <a href=\"https://seekingalpha.com/pr/17123064-nokia-nokia-ranked-1-china-mobile-central-bid-will-provide-transport-network-support-data\" target=\"_blank\">ranked it No. 1</a> in a central bid to supply its regional optical transport network.</li>    <li>The new optical backbone for 13 metro and two provincial networks will let China Mobile improve support for data center interconnect, broadband and 4G services, with 5G on the horizon.</li>    <li>Nokia's 1830 PSS-24x platform is at the core of the new network, a multilayer platform offering massive switching scale with high-performance optics.</li>    <li>NOK is <font color='green'>up 1.1%</font> premarket; <a href='https://seekingalpha.com/symbol/CHL' title='China Mobile Limited'>CHL</a> is <font color='green'>up 2.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344390\" data-linked=\"Nokia ranked No. 1 in China Mobile&#39;s central network bid\" data-tweet=\"$NOK $NOK $CHL - Nokia ranked No. 1 in China Mobile&#39;s central network bid https://seekingalpha.com/news/3344390-nokia-ranked-no-1-in-china-mobiles-central-network-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3344390-nokia-ranked-no-1-in-china-mobiles-central-network-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344387\" data-ts=\"1523280364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAD\" target=\"_blank\">ACAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344387-acadia-pharma-down-17-premarket-on-nuplazid-safety-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acadia Pharma down 17% premarket on Nuplazid safety concerns</a></h4><ul><li>Acadia Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a>) slumps&nbsp;<font color='red'>17%</font>&nbsp;on increased volume in apparent response to a <a href=\"https://www.cnn.com/2018/04/09/health/parkinsons-drug-nuplazid-invs/index.html?no-st=1523280024\" target=\"_blank\">CNN article</a> on the incidence of reported adverse events related to NUPLAZID (pimavanserin), approved in the U.S. two years ago for Parkinson's disease psychosis &#40;PDP&#41;.</li><li>According to the non-profit Institute for Safe Medication Practices, there were 244 deaths reported to the FDA within the first year after launch and now over 700 to date. It was listed a \"suspect\" in at least 500 mortalities.</li><li><strong>Update</strong>: In a <a href=\"https://www.documentcloud.org/documents/4433424-ACADIA-Response.html\" target=\"_blank\">statement</a>, the company says the overall mortality rate for the drug is 12.4/100 patient years, less than half of overall mortality rate of 28.2/100 patient years in people with PDP. It also says it maintains a close watch on safety reports to ensure that NUPLAZID performs as expected, adding that two studies in Alzheimer's patients (after FDA approval for PDP) with dementia showed no difference in mortality rates versus placebo.</li><li>It also cautions on drawing conclusions from the adverse event data since it does not mean that the medication caused the event.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344387\" data-linked=\"Acadia Pharma down 17% premarket on Nuplazid safety concerns\" data-tweet=\"$ACAD - Acadia Pharma down 17% premarket on Nuplazid safety concerns https://seekingalpha.com/news/3344387-acadia-pharma-down-17-premarket-on-nuplazid-safety-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3344387-acadia-pharma-down-17-premarket-on-nuplazid-safety-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>90&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344385\" data-ts=\"1523280318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KGC\" target=\"_blank\">KGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344385-kinross-gold-seen-loser-rio-tinto-winner-in-u-s-sanctions-on-russia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kinross Gold seen as loser, Rio Tinto a winner in U.S. sanctions on Russia</a></h4><ul>     <li>Kinross Gold (NYSE:<a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a>) <font color='red'>-5.3%</font> pre-market as new U.S. sanctions <a href=\"https://seekingalpha.com/news/3344364-aluminum-price-rallies-u-s-sanctions-russia\" target=\"_blank\">caused Russian markets to tumble</a>, as ~20% of KGC&rsquo;s production this year will come from Russia.</li>     <li>Conversely, industry sources say Rio Tinto (NYSE:<a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a>) will be <a href=\"https://www.reuters.com/article/us-rusal-sanctions-aluminium/rio-tinto-stands-to-win-from-rusal-sanctions-u-s-consumers-to-lose-idUSKBN1HG1NL\" target=\"_blank\">among the biggest winners</a> from sanctions imposed on Russian aluminum giant Rusal, as it is considered well placed to replace Russian metal flows; RIO <font color='green'>+1.2%</font> premarket.</li><li>Traders and analysts say the sanctions should accelerate a rerouting of  global aluminum shipments that began last month after the U.S. imposed a  10% duty on aluminum imports under Section 232 of U.S. trade laws.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344385\" data-linked=\"Kinross Gold seen as loser, Rio Tinto a winner in U.S. sanctions on Russia\" data-tweet=\"$KGC $KGC $RIO - Kinross Gold seen as loser, Rio Tinto a winner in U.S. sanctions on Russia https://seekingalpha.com/news/3344385-kinross-gold-seen-loser-rio-tinto-winner-in-u-s-sanctions-on-russia?source=tweet\" data-url=\"https://seekingalpha.com/news/3344385-kinross-gold-seen-loser-rio-tinto-winner-in-u-s-sanctions-on-russia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344383\" data-ts=\"1523280060\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344383-pareteumplus-5_2-on-preliminary-revenues-up-47\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum +5.2% on preliminary revenues up 47%</a></h4><ul>   <li>Pareteum (NYSEMKT:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) is <font color='green'>up 5.2%</font> premarket after a preannouncement that it's expecting to report <a href=\"https://seekingalpha.com/pr/17123521-pareteums-q1-2018-revenue-expected-4_1-million-47-percent-increase-q1-2017\" target=\"_blank\">quarterly revenues of at least $4.1M</a>, up 47% Y/Y.</li>    <li>Connections (a leading indicator for revenue) rose 94% Y/Y to 2.22M. That figure's up 30% sequentially and management says it gives them confidence in full-year outlook for 50% revenue growth.</li>    <li>The company expects to release results and hold its call the week before May 15.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344383\" data-linked=\"Pareteum +5.2% on preliminary revenues up 47%\" data-tweet=\"$TEUM - Pareteum +5.2% on preliminary revenues up 47% https://seekingalpha.com/news/3344383-pareteumplus-5_2-on-preliminary-revenues-up-47?source=tweet\" data-url=\"https://seekingalpha.com/news/3344383-pareteumplus-5_2-on-preliminary-revenues-up-47\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344381\" data-ts=\"1523279826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYEG\" target=\"_blank\">EYEG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344381-eyegate-sees-q3-start-for-second-pilot-study-of-lead-candidate-eyegate-obg-shares-slip-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EyeGate sees Q3 start for second pilot study of lead candidate EyeGate OBG; shares slip 6% premarket</a></h4><ul><li>Thinly traded nano cap EyeGate Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/EYEG' title='EyeGate Pharmaceuticals'>EYEG</a>) eases&nbsp;<font color='red'>6%</font>&nbsp;premarket on higher-than-normal volume on the heels of its <a href=\"https://seekingalpha.com/pr/17123475-eyegate-receives-fda-feedback-investigational-device-exemption-amendment-second-pilot-study\" target=\"_blank\">announcement</a> that it is making progress in obtaining FDA sign-off on a second pilot study assessing lead candidate EyeGate Ocular Bandage Gel &#40;OBG&#41; for the acceleration of re-epithelialization of larger corneal epithelial defects in patients who have undergone <a href=\"https://www.aao.org/eye-health/treatments/photorefractive-keratectomy-prk\" target=\"_blank\">photorefractive keratectomy</a> (type of laser surgery to correct nearsightedness).</li><li>In a letter, the FDA identified four deficiencies in the company's submission. It has requested additional information on the manufacturing processes and clarification of certain previously submitted data and modifications to manufacturing process documents.</li><li>The company says it is in the process of responding to the FDA items and expects to launch the 45-subject study in Q3. Topline results should be available in Q4. The primary objective is to compare EyeGate OBG to standard-of-care treatment (bandage contact lens plus artificial tears).</li></ul><div class=\"tiny-share-widget\" data-id=\"3344381\" data-linked=\"EyeGate sees Q3 start for second pilot study of lead candidate EyeGate OBG; shares slip 6% premarket\" data-tweet=\"$EYEG - EyeGate sees Q3 start for second pilot study of lead candidate EyeGate OBG; shares slip 6% premarket https://seekingalpha.com/news/3344381-eyegate-sees-q3-start-for-second-pilot-study-of-lead-candidate-eyegate-obg-shares-slip-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3344381-eyegate-sees-q3-start-for-second-pilot-study-of-lead-candidate-eyegate-obg-shares-slip-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344378\" data-ts=\"1523279514\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRPX\" target=\"_blank\">TRPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344378-premarket-gainers-of-9-05-04-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (04/09/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a> <font color='green'>+25%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3344327-therapix-biosciences-announces-results-phase-iia-study-tourette-syndrome-program-shares-ahead\" target=\"_blank\">announcing</a> results of Phase IIa study at for Tourette syndrome program.</li><li><a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a> <font color='green'>+17%</font>&nbsp;as FDA <a href=\"https://seekingalpha.com/news/3344312-fda-accepts-verastems-marketing-application-blood-cancer-med-duvelisib-action-date-october-5\" target=\"_blank\">accepts</a> marketing application for blood cancer med duvelisib.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344378\" data-linked=\"Premarket Gainers as of 9:05 am (04/09/2018)\" data-tweet=\"$TRPX $TRPX $VSTM - Premarket Gainers as of 9:05 am (04/09/2018) https://seekingalpha.com/news/3344378-premarket-gainers-of-9-05-04-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344378-premarket-gainers-of-9-05-04-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344376\" data-ts=\"1523279361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNLO\" target=\"_blank\">MNLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344376-premarket-losers-of-9-05-4-9-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (4/9/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/MNLO' title='Menlo Therapeutics Inc.'>MNLO</a>&nbsp;<font color='red'>-64%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3344347-menlo-therapeutics-lead-candidate-flunks-mid-stage-study-shares-55-percent-premarket\" target=\"_blank\">announcing</a> results from a Phase 2 Trial of Serlopitant for pruritus associated with AD.</li><li><a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a> <font color='red'>-20%</font>.</li><li><a href='https://seekingalpha.com/symbol/YNDX' title='Yandex N.V.'>YNDX</a> <font color='red'>-7%</font>.</li><li><a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3344376\" data-linked=\"Premarket Losers as of 9:05 am (4/9/2018)\" data-tweet=\"$MNLO $MNLO $ACAD - Premarket Losers as of 9:05 am (4/9/2018) https://seekingalpha.com/news/3344376-premarket-losers-of-9-05-4-9-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3344376-premarket-losers-of-9-05-4-9-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344375\" data-ts=\"1523279055\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344375-apples-red-iphone-8-models-release-tomorrow\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple&#39;s red iPhone 8 models release tomorrow</a></h4><ul><li>        Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) <a href=\"https://www.theverge.com/circuitbreaker/2018/4/9/17214488/product-red-iphone-8-plus-apple-announced-price-release-date\" target=\"_blank\">introduces</a> red models of the iPhone 8 and 8 Plus. The phones are tied to Project &#40;RED&#41;, an organization fighting HIV and AIDS in Africa. &nbsp;</li><li>        A portion of proceeds from the phone sales will go to Project &#40;RED&#41;.</li><li>               Preorders begin tomorrow and shipping starts on Friday. The price is the same as the standard iPhone 8 models, but availability will likely be limited since last year&rsquo;s red phones went away when the new phones were released.&nbsp;</li><li>               Apple shares are&nbsp;<font color='green'>up 1%</font>&nbsp;premarket to $170.10&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3344375\" data-linked=\"Apple&#39;s red iPhone 8 models release tomorrow\" data-tweet=\"$AAPL - Apple&#39;s red iPhone 8 models release tomorrow https://seekingalpha.com/news/3344375-apples-red-iphone-8-models-release-tomorrow?source=tweet\" data-url=\"https://seekingalpha.com/news/3344375-apples-red-iphone-8-models-release-tomorrow\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344374\" data-ts=\"1523279049\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSYS\" target=\"_blank\">RSYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344374-radisys-up-7-premarket-on-announcing-preliminary-q1-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Radisys up 7% premarket on announcing preliminary Q1 guidance</a></h4><ul> <li>Radisys Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/RSYS' title='RadiSys Corporation'>RSYS</a>) <a href=\"https://seekingalpha.com/pr/17123278-radisys-announces-preliminary-first-quarter-revenue-exceeding-high-end-guidance-range\" target=\"_blank\">announces</a> preliminary Q1 2018 revenue of       ~$25.5M, exceeding the high-end of the prior guidance range of $22M to $24M. Non-GAAP EPS is expected in the range of of ($0.12) to ($0.08) per share.</li>          <li>Complete Q1 2018 results are scheduled to be reported on May 1.</li><li>Shares are up&nbsp;<font color='green'>7%</font>&nbsp;premarket.</li>          </ul><div class=\"tiny-share-widget\" data-id=\"3344374\" data-linked=\"Radisys up 7% premarket on announcing preliminary Q1 guidance\" data-tweet=\"$RSYS - Radisys up 7% premarket on announcing preliminary Q1 guidance https://seekingalpha.com/news/3344374-radisys-up-7-premarket-on-announcing-preliminary-q1-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3344374-radisys-up-7-premarket-on-announcing-preliminary-q1-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344367\" data-ts=\"1523278062\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAYC\" target=\"_blank\">PAYC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344367-paycom-softwareplus-1_5-on-target-boost-to-17-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Paycom Software +1.5% on target boost to 17% upside</a></h4><ul><li>           Dougherty &amp; Co. raises its Paycom Software (NYSE:<a href='https://seekingalpha.com/symbol/PAYC' title='Paycom Software, Inc.'>PAYC</a>) price target from $100 to $125, a nearly 17% upside to Friday&rsquo;s close. </li><li> Firm cites Paycom&rsquo;s strong performance YTD that&rsquo;s forcing investors to argue valuation versus expected strength and long-term fundamental evolution. </li><li> Dougherty says Paycom is trading at a premium multiple at 9.3x EV/Sales on FY19E but the company continues to build a pipeline for 2019 and beyond and is on track to re-accelerate new office openings this year.&nbsp; </li><li> Source: Briefings.com. </li><li> Paycom Software shares are&nbsp;<font color='green'>up 1.5%</font>&nbsp;to $108.79.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3344367\" data-linked=\"Paycom Software +1.5% on target boost to 17% upside\" data-tweet=\"$PAYC - Paycom Software +1.5% on target boost to 17% upside https://seekingalpha.com/news/3344367-paycom-softwareplus-1_5-on-target-boost-to-17-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3344367-paycom-softwareplus-1_5-on-target-boost-to-17-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344361\" data-ts=\"1523277497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BABA\" target=\"_blank\">BABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344361-ant-financial-head-steps-down-for-lazada-role\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ant Financial head steps down for Lazada role</a></h4><ul><li>           The chairman of Alibaba&rsquo;s (NYSE:<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a>) Ant Financial arm has <a href=\"https://www.wsj.com/articles/chairman-of-alibaba-affiliate-ant-financial-steps-down-1523266283?mod=rss_Technology\" target=\"_blank\">stepped down</a>. </li><li> Lucy Peng led Ant Financial for eight years and will now run Lazada Group, an e-commerce operator Alibaba is using to expand in Southeast Asia. </li><li> Current Ant CEO Eric Jing will take on the chairman role effective immediately in addition to his existing duties. &nbsp; </li><li> Alibaba shares are&nbsp;<font color='green'>up 1.7%</font>&nbsp;premarket.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3344361\" data-linked=\"Ant Financial head steps down for Lazada role\" data-tweet=\"$BABA - Ant Financial head steps down for Lazada role https://seekingalpha.com/news/3344361-ant-financial-head-steps-down-for-lazada-role?source=tweet\" data-url=\"https://seekingalpha.com/news/3344361-ant-financial-head-steps-down-for-lazada-role\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344358\" data-ts=\"1523276962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTRA\" target=\"_blank\">NTRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344358-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Natera (NASDAQ:<a href='https://seekingalpha.com/symbol/NTRA' title='Natera'>NTRA</a>) initiated with Buy rating and $16 (82% upside) price target at Craig Hallum. Shares up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume.</li><li>Argenx (NASDAQ:<a href='https://seekingalpha.com/symbol/ARGX' title='Argenx SE'>ARGX</a>) initiated with Buy rating and $125 (67% upside) price target at SunTrust. Shares up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume.</li><li>DarioHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/DRIO' title='DarioHealth Corp.'>DRIO</a>) initiated with Buy rating and $4 (155% upside) price target at Chardan.</li><li>Arcus Biosciences (NYSE:<a href='https://seekingalpha.com/symbol/RCUS' title='Arcus Biosciences'>RCUS</a>) initiated with Outperform rating and $21 (46% upside) price target at Leerink. Initiated with Buy rating and $18 price target at Citigroup. Initiated with Neutral rating with an $18 price target at Goldman.</li><li>Agilent (NYSE:<a href='https://seekingalpha.com/symbol/A' title='Agilent Technologies Inc.'>A</a>) upgraded to Buy at Goldman. Shares up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume.</li><li>Regeneron Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a>) downgraded to Market Perform at Raymond James. Shares down a fraction premarket.</li><li>Menlo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MNLO' title='Menlo Therapeutics Inc.'>MNLO</a>) downgraded to Hold at Jefferies.&nbsp;Shares down&nbsp;<font color='red'>59%</font>&nbsp;premarket on light volume on failed Phase 2 study.</li><li>NewLink Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/NLNK' title='NewLink Genetics Corporation'>NLNK</a>) downgraded to Neutral at Cantor Fitzgerald, Robert W. Baird and Jefferies.</li><li>Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) price target cut to $78 (22% upside) from $145 at Credit Suisse after epacadostat flop. Shares up&nbsp;<font color='green'>2%</font>&nbsp;premarket on modest volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344358\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$NTRA $NTRA $ARGX - Premarket analyst action - healthcare https://seekingalpha.com/news/3344358-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3344358-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344357\" data-ts=\"1523276929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIMO\" target=\"_blank\">SIMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344357-silicon-motion-announces-preliminary-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Silicon Motion announces preliminary Q1 results</a></h4><ul><li>        Silicon Motion (NASDAQ:<a href='https://seekingalpha.com/symbol/SIMO' title='Silicon Motion Technology Corporation'>SIMO</a>) <a href=\"https://seekingalpha.com/pr/17123387-silicon-motion-announces-preliminary-first-quarter-2018-revenue-earnings-conference-call\" target=\"_blank\">announces</a> preliminary Q1 results with revenue expected near the midpoint of its $127M to $132M guidance range (consensus: $129.61M.)</li><li>                  Non-GAAP gross margin expected in the upper half of 46.5% to 48.5% guidance.    </li><li>               Silicon Motion will report its Q1 results on April 26.&nbsp;</li><li>               Silicon Motion shares are&nbsp;<font color='green'>up 0.3%</font>&nbsp;premarket to $47.80.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3344357\" data-linked=\"Silicon Motion announces preliminary Q1 results\" data-tweet=\"$SIMO - Silicon Motion announces preliminary Q1 results https://seekingalpha.com/news/3344357-silicon-motion-announces-preliminary-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3344357-silicon-motion-announces-preliminary-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344355\" data-ts=\"1523276770\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOG\" target=\"_blank\">NOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344355-northern-oil-gasplus-7-stifel-awards-buy-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northern Oil &amp; Gas +7% as Stifel awards Buy rating</a></h4><ul>     <li>Northern Oil &amp; Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a>)&nbsp;<font color='green'>+7.4%</font> premarket after Stifel initiates coverage with a <a href=\"https://www.streetinsider.com/Analyst+Comments/Stifel+Starts+Northern+Oil+and+Gas+%28NOG%29+at+Buy%2C+Only+Bakken+Pure-Play+In+The+Sector+at+Present/14033338.html\" target=\"_blank\">Buy rating</a> and a $3.10 price target, citing its strong position in the Willistion Basin.</li>     <li>Stifel says the Williston Basin is quickly becoming the preferred quality basin for investors to hedge their Permian Basin exposure because of improving trends in asset productivity and differentials; as a result of NOG's strategic business model, the company has the opportunity to participate in the best wells in the basin and acquire highly accretive assets in an environment with limited buyer competition, the firm says.</li>     <li>Equally important, Stifel says, is that NOG is the only Bakken pure-play in the sector at present.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344355\" data-linked=\"Northern Oil &amp; Gas +7% as Stifel awards Buy rating\" data-tweet=\"$NOG - Northern Oil &amp; Gas +7% as Stifel awards Buy rating https://seekingalpha.com/news/3344355-northern-oil-gasplus-7-stifel-awards-buy-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3344355-northern-oil-gasplus-7-stifel-awards-buy-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344353\" data-ts=\"1523276361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/F\" target=\"_blank\">F</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344353-morgan-stanley-positive-on-detroit-automakers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley positive on Detroit automakers</a></h4><ul> <li>Morgan Stanley Adam Jonas sees <a href=\"https://www.cnbc.com/2018/04/09/gm-shares-jump-on-upgrade-by-widely-followed-analyst-at-morgan-stanley.html\" target=\"_blank\">better times</a> ahead for Detroit automakers.</li> <li>\"We see room for positive earnings revisions for Ford, GM and FCA as investors better understand the dynamic between US pick-up truck sales and the spending/economic outcomes triggered by a potential passage of a US infrastructure bill,\" writes Jonas in a fresh note to clients.</li> <li>In particular, Jonas is positive on GM's prospects, upgrading the automaker to Overweight from Equal-weight and assigning a price target of $45 (27% upside).</li> <li>\"We believe that GM's markedly improved valuation post sell-off, higher price target derived from our increased pickup truck business valuation in the SOTP [sum of the parts] and tempered Auto 2.0 expectations merit an upgrade,\" says Jonas.</li> <li>GM <font color='green'>+2.55%</font> premarket to $38.64. Ford (NYSE:<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a>) is <font color='green'>up 1.07%</font> to $11.30. Fiat Chrysler (NYSE:<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a>) is <font color='green'>1.30% higher</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3344353\" data-linked=\"Morgan Stanley positive on Detroit automakers\" data-tweet=\"$F $F $FCAU - Morgan Stanley positive on Detroit automakers https://seekingalpha.com/news/3344353-morgan-stanley-positive-on-detroit-automakers?source=tweet\" data-url=\"https://seekingalpha.com/news/3344353-morgan-stanley-positive-on-detroit-automakers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344350\" data-ts=\"1523276001\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344350-coalition-files-ftc-complaint-accusing-youtube-of-child-data-violations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coalition files FTC complaint accusing YouTube of child data violations</a></h4><ul><li>        A coalition of advocacy, consumer, and privacy groups <a href=\"https://www.cnbc.com/2018/04/09/googles-youtube-illegally-collects-childrens-data-privacy-groups-claim.html\" target=\"_blank\">files an FTC complaint</a> accusing YouTube (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a>) of violating child protection laws with data collection.</li><li>               The coalition wants Google to change content management for its younger audience and wants YouTube to pay billions in fines for profiting from the data of children.&nbsp;</li><li>               The complaint cites the Children&rsquo;s Online Privacy Protection Act and says YouTube tracked the activity of children across websites to target ads without parental consent.&nbsp;</li><li>               Google tells CNBC it hasn&rsquo;t received the complaint yet but that &ldquo;protecting kids and families has always been a top priority.&rdquo; &nbsp;&nbsp;</li><li>               GOOG shares are&nbsp;<font color='green'>up 1.2%</font>&nbsp;premarket to $1,019.30.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3344350\" data-linked=\"Coalition files FTC complaint accusing YouTube of child data violations\" data-tweet=\"$GOOG $GOOG $GOOGL - Coalition files FTC complaint accusing YouTube of child data violations https://seekingalpha.com/news/3344350-coalition-files-ftc-complaint-accusing-youtube-of-child-data-violations?source=tweet\" data-url=\"https://seekingalpha.com/news/3344350-coalition-files-ftc-complaint-accusing-youtube-of-child-data-violations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344347\" data-ts=\"1523275805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNLO\" target=\"_blank\">MNLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344347-menlo-therapeutics-lead-candidate-flunks-mid-stage-study-shares-down-55-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Menlo Therapeutics&#39; lead candidate flunks mid-stage study; shares down 55% premarket</a></h4><ul><li>Thinly traded small cap and relatively recent IPO Menlo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MNLO' title='Menlo Therapeutics Inc.'>MNLO</a>) slumps&nbsp;<font color='red'>55%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17123025-menlo-therapeutics-announces-results-phase-2-trial-serlopitant-pruritus-associated-atopic\" target=\"_blank\">announcement </a>that lead candidate serlopitant failed to separate from placebo in a Phase 2 clinical trial in patients with itching due to atopic dermatitis.</li><li>The study, ATOMIK, failed to achieve its primary or key secondary endpoints.</li><li>CEO Steve Basta says, &ldquo;While we are disappointed that the results in this Phase 2 trial of pruritus associated with atopic dermatitis did not reach statistical significance and did not show the same magnitude of treatment effect as in our prior pruritus studies, we do see in the results a pattern that shows numerical improvement in each serlopitant treatment group above the placebo group at every time point.&nbsp; This is our third pruritus study of serlopitant. &nbsp;Reduction of pruritus has been demonstrated in two prior Phase 2 studies, one trial in patients with chronic pruritus and one trial in patients with prurigo nodularis. We are initiating Phase 3 studies in prurigo nodularis this quarter, and we are looking forward to the Phase 2 results in refractory chronic cough in the fourth quarter of this year, and the Phase 2 results in pruritus associated with psoriasis by late 2018 or early 2019.&rdquo;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320737-menlo-therapeutics-deck-ipo\" target=\"_blank\">Menlo Therapeutics on deck for IPO</a> (Jan. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3344347\" data-linked=\"Menlo Therapeutics&#39; lead candidate flunks mid-stage study; shares down 55% premarket\" data-tweet=\"$MNLO - Menlo Therapeutics&#39; lead candidate flunks mid-stage study; shares down 55% premarket https://seekingalpha.com/news/3344347-menlo-therapeutics-lead-candidate-flunks-mid-stage-study-shares-down-55-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3344347-menlo-therapeutics-lead-candidate-flunks-mid-stage-study-shares-down-55-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3344339\" data-ts=\"1523275174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APOP\" target=\"_blank\">APOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3344339-cellect-bio-up-21-premarket-on-advancement-of-new-stem-cell-production-technique\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellect Bio up 21% premarket on advancement of new stem cell production technique</a></h4><ul><li>Thinly traded nano cap Cellect Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/APOP' title='Cellect Biotechnology Ltd.'>APOP</a>) is up&nbsp;<font color='green'>21%</font>&nbsp;premarket on modestly higher volume on the heels of its <a href=\"https://seekingalpha.com/pr/17123210-cellect-announces-major-milestone-enabling-stem-cells-production\" target=\"_blank\">announcement </a>that it has successfully completed proof-of-concept testing of ApoTainer, a new scalable method for manufacturing stem cells that it says is much more effective than bone marrow transplantations at a fraction of the time and cost.</li><li>ApoTainer uses specially coated magnetic beads which significantly increases the active surface thereby increasing the interactions between the selecting agent and the cells. The prototype was able to increase the elimination of more non-stem cells while preserving the number and function of stem and progenitor cells.</li><li>The company says ApoTainer will enable a blood stem cell donation to be transplantable less than six hours from donation at the hospital bedside.</li></ul><div class=\"tiny-share-widget\" data-id=\"3344339\" data-linked=\"Cellect Bio up 21% premarket on advancement of new stem cell production technique\" data-tweet=\"$APOP - Cellect Bio up 21% premarket on advancement of new stem cell production technique https://seekingalpha.com/news/3344339-cellect-bio-up-21-premarket-on-advancement-of-new-stem-cell-production-technique?source=tweet\" data-url=\"https://seekingalpha.com/news/3344339-cellect-bio-up-21-premarket-on-advancement-of-new-stem-cell-production-technique\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}